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ABSTRACT OF THE DISSERTATION

Integrated Mass Spectrometry-Based Method in Protein Chemistry:
Metal-binding Protein and Integral Membrane Protein
by
Chunyang Guo
Doctor of Philosophy in Chemistry
Washington University in St. Louis, 2020
Professor Michael L. Gross, Chair

Most biological processes are associated with protein catalysis. Characterizing protein structure,
therefore, is crucial for understanding biological function. Mass spectrometry (MS)-based
methods have emerged as a pivotal biophysical tool to interrogate protein structures; they can
characterize protein-ligand/protein complexes that are refractory to conventional high-resolution
means such as X-ray crystallography, Cryo-EM, and nuclear magnetic resonance (NMR)
spectroscopy, in part owing to high molecular weight and significant flexibility. The integrated
MS-based platform will provide topology and structural information of proteins from sketch to
detail; native MS identifies protein complexes’ composition and stoichiometry; hydrogendeuterium exchange MS (HDX-MS) detects the protein complexes’ dynamic change at the
peptide-level and sometimes at the residue-level; protein footprinting coupled with MS pinpoints
the binding site at residue-level via irreversible chemical changes. This thesis comprising eight
chapters focuses on method development and application of integrated MS-based platform, using
examples of metal-binding proteins and integral membrane proteins that illustrate challenges and
solutions.
xv

Chapter 1 provides a brief history of MS, the significance of metal-binding proteins and integral
membrane proteins, and the fundamentals and applications of integrated MS-based platform on
these proteins.
Chapter 2 covers the introduction of metal-binding proteins and previous method development
in this field. We selected Ca(II) and Mg(II) binding calmodulin (CaM) as protein models due to
these cations’ high abundance in metalloproteins. Ca(II) and Mg(II) bind to CaM through
chelating carboxylic acid residues.

To map the metal-binding sites, we developed a new

carboxyl group footprinter, benzhydrazide, and refined it with isotope encoding coupled with
mass spectrometry detection. The study demonstrated that the reactive benzhydrazide can
discriminate metal-binding sites, which should be important for locating metal-binding sites of
other metalloproteins.
Chapter 3 describes collaborative work with Dr Jeffrey P. Henderson from department of
medicine at Wash U. We applied an integrated MS-based platform, including native MS, HDXMS, and Lys/Arg specific covalent footprinting, to characterize linear Enterobactin (lin-Ent)
interactions with an innate immune protein siderocalin (Scn) in the presence or absence of iron.
The results have raised the possibility that Scn neutralizes both siderophore and iron-bound
siderophore during infections. Our strategy, circumventing the limitations that frustrate
traditional structural approaches, screened and characterized Scn interactions with enterobactinbased ligands with high-throughput.
Chapter 4 reports a method development that solves the digestion problem when we
encountered in Chapter 3—utilizing organic solvents to enhance proteolysis of stable proteins for
HDX-MS. Although HDX-MS has been widely applied to interrogate high-order structure of
proteins, it remains challenging for stable ß-barrel proteins, which act as cellular transporters,

xvi

enzymes, and receptors. Digestion difficulty for bottom-up measurements arises from ß-barrel
proteins’ stable structure that contains a continuous chain of H-bonds. The study tested organic
solvents as denaturants for on-line pepsin digestion, evaluated the digestion efficiency, and
concluded that organic solvents can improve the protein digestion without compromising the
ability to predict binding site when adopting this proteolysis on HDX-MS.
Chapter 5 presents description of how we expanded a MS-based protein footprinter DEPC to
integral membrane protein labeling. The relatively hydrophobic DEPC, facilitated by tip
sonication, can diffuse into micelles and subsequently modify the hydrophobic transmembrane
domain; the modification of strongly nucleophilic residues matched well with the protein’s highorder structure. Compared with hydrophilic reagent that solely modifies the extramembrane
domain, this study inspired us to link the reagent’s hydrophobicity with the transmembrane
domain labeling. Thus, we can study the relationship between reagent’s hydrophobicity and the
preferential labeling sites, so that we can use it as a guidance to develop footprinters with
appropriate hydrophobicity for membrane protein labeling.
Chapter 6 tackles a problem left from the previous chapter. We selected a series of photoactivable iodine reagents with a hydrophobicity gradient to test whether the more hydrophobic
reagent labels a transmembrane domain more efficiently. Quantification by proteolysis and LCMS/MS allowed a comparison of the modification extent in extramembrane and transmembrane
domain, the relationship between the reagent’s hydrophobicity and their preferential labeling
sites in local environment. The outcome will guide to the development of novel chemical probes
for membrane protein study in vivo.
Chapter 7 demonstrates that we pushed the boundary of MS-based protein footprinting by
applying the method developed in Chapter 6 to label integral membrane proteins that reside in a

xvii

native-like membrane. We reconstituted membrane proteins in liposomes to maintain the nativelike environment and labeled the protein with three photo-activable organic iodine reagents that
we implemented in Chapter 6. Besides confirming the applicability of photo-activable iodine
reagents in a liposome system, the results also revealed that these reagents follow the same
labeling trend as in micelle. This study lays the foundation for further in-cell membrane protein
labeling.
Chapter 8 provides a conclusion for my dissertation. We discussed perspectives for integrated
MS-based methods and their roles in structural biology to reveal the architecture and functions of
proteins.

xviii

Chapter 1: Introduction of MS-based
Structural Proteomics in Metal-Binding
Protein and Integral Membrane Protein
1.1 Abstract
Metal-binding proteins and membrane proteins play key roles in mediating cellular processes.
Characterizing proteins, including revealing protein high-order structure, probing protein-ligand
or protein-protein interactions, and detecting protein conformational change, help us understand
their structures, functions, and interactions to solve biological problems. Rapid development of
mass spectrometry (MS) has resulted in significant advances in structural proteomics to address
the above protein structural questions. Mass spectrometrists group MS-based methods into two
types based on the level of provided structural information: protein-centric and peptide-centric
strategies. Protein-centric strategy—native MS—characterizes the intact protein and determines
the protein complexes binding stoichiometry and subunit connectivity. Peptide-centric strategies
comprise hydrogen deuterium exchange, irreversible covalent labeling, cross-linking, and limited
proteolysis. Each method provides specific and unique structural information: HDX-MS
determines the hydrogen bonding status and protein’s solvent accessibility at the peptide-level;
irreversible covalent labeling provides surface amino-acid residue’s solvent accessibility at
peptide- or residue-level; chemical cross-linking measures the distance between two subunits or
proteins by cross-linking them with bifunctional reagents; limited proteolysis indicates large
portions of the protein that are solvent-exposed. An integrated MS-based platform will provide
various levels of structural information to generate comprehensive pictures of proteins. We
aimed to develop both novel water-soluble and lipophilic footprinters, search for and evaluate the
1

criteria for footprinters, and optimize the workflow, to integrate and develop MS-based structural
proteomics methods for metal-binding and membrane proteins’ studies. In the thesis, we
introduce both metal-binding proteins and membrane proteins, and review their significance and
function. Next, we discuss MS-based structural biology, including: 1) basic principles; 2) issues
in measurement; and 3) strategies to address biological problems. Particularly, we highlight
native MS, HDX-MS, and irreversible covalent labeling MS. Finally, we critically review how
selected applications help examine membrane proteins and metal-binding proteins’ structures,
functions, and interactions, summarize their limitations, and emphasize how our strategies will
fill the gaps.

1.2 Metal-Binding Protein and Membrane Protein
Proteins participate in most of the biological processes.
structure principle,

2

1

Guided by function-dictated-by-

scientists have sought to characterize protein structures to predict and

understand their function and properties. In this thesis, we will focus on metal-binding proteins
and membrane proteins.
Metal-binding proteins, comprising 25-50% of the proteome, participate in biochemical
processes throughout all domains of life. They bind and utilize metals to stabilize protein
structure, catalyze enzyme, and play a role in muscle contraction.

3-5

Each metal shows unique

features; for example, calcium and magnesium mediate cell signaling and muscle contraction;
iron triggers oxidation-reduction reactions and radical chemistry; copper transfers electrons.

6

Scientists have obtained a wealth of knowledge that metalloproteins execute functions depending
on an interplay of metal-binding, but the type of metal coordination, the orientation of the amino
acids around the metal-binding sites remain unclear, motivating scientists to study how metal

2

coordination affects a protein’s reactivity. In this thesis, we will focus the metals—Ca, Mg, and
Fe—that dominate metalloproteins 7 (Figure 1.1).
In Chapter 2, we discuss biogenic cations Ca(II), Mg(II), abundant among metalloproteins,

3-5

stabilize the structure of folded proteins, and in some cases, lock in an active conformation.

6,7

Specifically, Ca(II) plays a role in signal transduction, nerve-impulse transmission, and calcium
homeostasis. Most Ca-binding proteins possess a highly conserved Ca-binding motif, the EF
hand, that selectively binds Ca in a background of up to 105-fold higher concentrations of Na(I),
K(I), and Mg(II).

8, 9

Although divalent Mg, with higher charge density, exists at higher

concentration in the cytosol than Ca(II), it shares physical and chemical properties with Ca(II). 10,
11

Figure 1.1 Abundance of a) metalloproteins (data were obtained from reference 6) and b) human membrane
proteins as drug targets (adapted from reference 20).

3

Iron, a transition metal, requires tight regulation because of the high toxicity in its free ionic
form; therefore, many proteins carry functions of sensing, transporting, and storing iron to
maintain iron homeostatic levels. 7, 12 Usually, iron plays a role in metalloenzymes, forming iron
centers, to catalyze reactions in biological systems.

13

In Chapter 3, instead of analyzing the

sophisticated iron-binding metalloenzymes, we study an innate immune protein—siderocalin—
that indirectly binds iron through simple and small organic molecules. Siderocalin employs
nutrient-starvation strategy to prevent pathogen obtaining iron ions and consequently defend
against the invading of pathogens and avoid the infection.
Membrane proteins turns out to be another important class of protein; they comprise 30% of the
proteome and 60% of the therapeutic targets, and play key role in mediating cellular processes,
including protein lipidation, post translation modifications, and cell signaling.

14-20

Generally,

membrane protein has a large hydrophobic transmembrane domain that inserts or spans the entire
membrane and a soluble extramembrane domain that orients inside or outside the cell.
Understanding the properties of transmembrane domains requires the solubilization of protein in
detergent or an artificial membrane (e.g., micelles, bicelles, amphipols, and lipid nanodiscs) to
mimic the lipid membrane environment. 14

1.3 Biophysical Tools for Protein Characterization
Structural biology is one of the growing areas of modern biology. Traditional biophysical tools
(e.g., circular dichroism (CD), UV spectroscopy, fluorescence) for characterizing proteins are a
“sledgehammer”: global, fast, and non-specific
like X-ray crystallography,

3, 23

cryo-EM,

21, 22

24, 25

(Figure 1.2). High-resolution techniques,

and NMR,

26, 27

have been utilized to study

proteins, but some limitations render them sometimes inapplicable.

14

X-ray crystallography

directly images the static protein, but fails to detect protein dynamics in solution. Another
4

impediment is crystalizing membrane proteins that must reside in lipid; this applies also to
crystalizing metalloproteins. NMR does not need a crystal but usually encounters problems of
protein size, aggregation propensity, or limited sample amount. Cryo-EM requires to trap or
enrich as many as possible protein conformational states. Researchers, who are on the forefront
of solving these problems, look for robust techniques for protein characterization that can
navigate in dynamic and unknown cellular environments.
Mass spectrometry (MS), providing moderate-resolution structural information, has established
itself a powerful tool over the past two decades for elucidating protein structures and detecting
protein dynamics in solution.

28

MS exhibits unique features that alleviate limitations associated

with high-resolution techniques, allowing us to collect and translate protein data from hard-toreach places: 1) avoid complicated sample preparation, like crystallization; 2) bypass protein size
restrictions; 3) require small amount of protein (fmol to pmol); 4) resolve co-populating
conformers; 5) detect protein dynamics under near-physiological conditions in solution with
high-throughput.

Figure 1.2 Biophysical tools for protein characterization (adapted from reference 1).

5

1.4 Mass Spectrometry Brief History
J. J. Thomson did groundbreaking work when studying cathode rays, which makes it possible to
develop a mass spectrometer as an analytical instrument in 1897.

29

Based on measuring atoms

mass-to-charge ratio in an electric or magnetic field, Thomson and Aston built the first mass
spectrometer. The first three decades in 20th century, scientists mainly applied mass
spectrometers in the field of isotope physics. The Manhattan Project during World War II further
pushed the development of mass spectrometers because scientists relied on them to separate
elemental isotopes for fissile material production. 30
In 1960-1970, the potential of mass spectrometer to analyze small molecules attracted the
attention from the oil industry. Pioneers like McLafferty, Biemann, and Djerassi addressed the
challenge and brought mass spectrometer into organic chemistry 30 (Figure 1.3).
Several years later, mass spectrometers entered the field of cellular, molecular, and structural
biology that can make giant “macromolecular elephants” fly. The advance took advantage of
introduction of electrospray ionization (ESI) and matrix-assisted laser desorption/ionization
(MALDI) in 1980s.

30

(Figure 1.3) The pioneers Koichi Tanaka and John Fenn received the

2002 Nobel Prize in Chemistry. Later, scientists expanded mass spectrometry’s application in
peptides and proteins by coupling with advanced separation methods, such as nanoflow liquid
chromatography and electrophoresis.

31, 32

Presently, we can analyze hundreds of thousands of

peptides in a day by combining it with advanced bioinformatics software and more sophisticated
and robust separation techniques, like reversed-phase, ion exchange chromatography.

33, 34

This

technique combined with structural proteomics has evolved as a standard and routine analysis for
recombinant proteins or proteins in cells, tissues, or organisms. 35, 36

6

1.5 Mass Spectrometry-Based Structural Proteomics
MS-based structural proteomics bridges analytical chemistry, protein chemistry, and biomedical
science together with modern mass spectrometry to obtain various types of experimental data for
detailed characterization of protein structure and protein-protein interactions.

37, 38

The methods

comprise native MS, HDX-MS, irreversible covalent labeling MS, cross-linking MS, and limited
proteolysis-MS (Figure 1.4).

Figure 1.3 Timeline of the development of mass spectrometer.

1.6 Protein-Centric Method: Native MS
Native MS or non-denaturing MS has made tremendous contributions to determine the
stoichiometry, topology, and subunit connectivity of intact proteins and protein complexes with
7

masses up to several MDa.

35, 39-43

Employing ESI to gently ionize proteins in a volatile buffer

solution (e.g., ammonium acetate), at conditions of physiological temperature and pH, low
ionization voltage, and atmospheric pressure, native MS maintains non-covalent interactions
(e.g., H-bonds, hydrophobic/ionic interactions).

22, 44

Recording the mass and mass shift of the

protein complexes, we can determine the stoichiometry and screen binding events; applying
controlled activation in a mass spectrometer to dissociate a protein complex in a step-way, we
can determine the subunit connectivity; monitoring protein’s charge state distribution, we can
detect the alternation of the protein: well-ordered and compact proteins exhibit a narrow charge
distribution with a few charge states, whereas the disordered and unstructured proteins display a
wide charge distribution with more charge states

45, 46

(Figure 1.4). Coupling native MS with

ion-mobility (IM) MS adds another dimension to protein analysis—by separating protein
conformers selected by time-of-flight to determine protein size and shape, the data of which can
be used to further calculate a protein’s collision cross section.

47

However, native MS is still

associated with limitations as follows: 22, 28, 37 1) Sticking to specific volatile buffers may hamper
the analysis of proteins that are not stable in a native MS compatible buffer. 2) Transferring the
protein from liquid to gas may alter the charge distribution and collision cross section;
hydrophobic and ionic interactions become weaker and stronger, respectively, in the gas phase,
leading to conformational perturbation. 3) The salt adducts, especially sodium adducts, decrease
sensitivity, cause peak broadening and ion suppression. 4) Native MS can effectively determine
overall binding stoichiometry and subunit connectivity, but it fails to provide even modest
structural information, like a protein’s binding-site and conformational change. The progress of
applying native MS to integral membrane proteins has been limited by the excess detergent
aggregates that solubilize proteins compromise the ionization, the membrane protein’s inherent
8

insolubility in MS-compatible buffers and ready dissociation of subunit interactions.
solve these problems, scientists have developed novel ionization method

50

48, 49

To

or extensively

removed the detergent. 51
Collectively, native MS needs to combine with peptide-centric methods to generate more
comprehensive pictures of the proteins.

1.7 Peptide-Centric Method
A wide variety of peptide-centric methods that couple a bottom-up approach with MS have
evolved as standard proteomics workflows to study protein folding, dynamics, and interactions.
35

The most promising methods comprise HDX, irreversible covalent labeling, cross-linking, and

limited proteolysis (Figure 1.4). In the following section, we will describe each method in more
detail.

1.7.1 Covalent Labeling Coupled with MS
Covalent modification in conjunction with MS is based on a reagent modifying functional groups
of solvent-accessible residues; the approach helps characterize protein high-order structure,
conformational changes, and binding sites.

52

Translating data of modification ratio into

structural information usually requires the labeling of different protein states; the buried regions
or protein interaction interfaces will be shielded from the labeling reagent and, thus, undergo less
modification, whereas the solvent-exposed regions undergo more modification.
To improve the quantification accuracy and reduce time of sample runs and data analysis,
investigators have developed isotope-encoded labeling reagents that are chemically identical but
different in mass.

52, 53

The workflow starts from labeling two states of the protein in a “light”

and “heavy” form, respectively. Then, the two labeled samples are combined in a 1:1 ratio
9

followed by sample digestion and MS analysis. Avoiding the separate runs of two states of the
protein samples, “light” and “heavy” modified peptides are analyzed by MS under same
instrumental conditions after they elute nearly simultaneously from the chromatography; this
allows researchers to quantify samples’ relative modification ratio in the same mass spectrum
with one sample run.
When applying covalent labeling MS on soluble proteins, like metal-binding proteins, we need to
ensure the reagents satisfy the following criteria: 1) remain inert in the aqueous buffer media in
the absence of the protein; 2) modify the protein with high reactivity; 3) label the protein with
either broad reactivity that can cover a wide variety of residues or with specific selectivity that
only target several residues; 4) form stable non-hydrolysable derivatives; 5) preserve protein’s
near native structure and functional integrity in solution during the labeling.
Challenges peculiar to membrane proteins requires additional considerations: 1) develop
lipophilic reagents that can diffuse into the membrane and detect the challenging transmembrane
domain because water-soluble reagents only label the extramembrane region; 2) choose suitable
artificial membrane (e.g., micelles, bicelles, nanodiscs, liposomes) to solubilize proteins; 3)
remove lipids after labeling to avoid contamination of a mass spectrometer; 4) optimize protein
digestion and peptide separation to achieve better detection. 14
Reversible Covalent Labeling: Hydrogen-Deuterium Exchange (HDX) MS
HDX-MS relies on measuring the differential exchange rate of amide hydrogens for a protein in
deuterated solvent to reveal altered protein regions—interaction interfaces or regions that
undergo conformational changes.54 The exchange rate reports on protein’s structural and surface
solvent accessibility: buried core, rigid, or tightly H-bonded regions exchange slowly, whereas
10

Figure 1.4 An overview of MS-based structural proteomics methods (reused with permission from reference 35).

11

the solvent-exposed, flexible, and unstructured regions exchange rapidly with deuterium (Figure
1.4). To determine spatial location, investigators most commonly conduct continuous labeling
experiment followed by bottom-up analysis. The experiment starts with incubating the protein in
D2O buffer for different time periods or vice versa, over quenching reaction at low pH (2.5) and
low temperature (0 oC), digesting the protein quickly with acidic protease (e.g., pepsin), and
analyzing the digested peptides by MS. Quenching the reaction quickly at low pH and
temperature drastically slows the exchange rate, so that we can “freeze” the reaction with
minimal hydrogen deuterium back-exchange and prevent introducing artifactual structural
information. In addition, pulse-labeling is also commonly used to study protein folding
mechanism or to study protein aggregation.

55-57

Alternatively, researchers take advantage of a

top-down approach in combination with electron capture dissociation (ECD)
transfer dissociation (ETD)

60

58, 59

or electron

to avoid hydrogen scrambling. Instead of digesting a protein, the

top-down approach infuses the intact protein, after exposing to D2O buffer solution, into mass
spectrometer for MS analysis and peptide sequencing. Exchanging with D2O can also be done in
the gas phase. 61
Though robustness of HDX-MS has made it an indispensable tool for structural studies,
exploring soluble protein structures remains tricky:

35, 37

1) Hydrogen deuterium back-exchange

during the labeling and digestion leads to lose structural information or introduce artifactual
results. 2) Saturation of all exchangeable protons might occur in few seconds, which is too short
to capture the structural difference by monitoring deuterium uptake. 3) Protease-resistant stable
proteins or proteins that lack specific cleavage sites limit the efficiency of pepsin, a commonly
used acidic protease for HDX-MS, resulting in poor sequence coverage, low spatial resolution,
and long peptides that experience ionization difficulty.
12

Another layer of difficulty was added when expanding HDX-MS to tackle challenging
membrane proteins:

35

1) getting access to hydrophobic transmembrane domain to obtain that

region’s structural information, 2) maintaining protein-lipid interaction during hydrogen
deuterium exchange to avoid protein aggregation/precipitation, 3) removing large excess of
lipids or detergents efficiently to avoid contamination of the MS and loss of peptide signal.
In view of these obstacles, researchers have made some improvements to streamline HDX-MS
workflow: 1) Optimizing the quench, protease, and LC-gradient to aid generating shorter
peptides, thus improving resolution and sequence coverage. For example, performing exchange
at low temperature (0 oC) and low pH (~5) decrease the exchange rate and allow monitoring fast
exchange,

62, 63

utilizing

denaturant like guanidine and reducing reagent (e.g., Tris(2-

carboxyethyl)phosphine (TCEP)) to unfold proteins,

64

employing a variety of acidic proteases

with different specificities to generate short peptides.

64-68

2) Developing methods for

maintaining protein-membrane interactions, including incubating membrane proteins and lipids
at high concentrations before initiating labeling,

69

and diluting membrane proteins and

membranes in the D2O buffer to simultaneously initiate protein-membrane interaction and the
deuteration of the complexes.

70

3) Extracting lipid and detergent before injecting samples to

mass spectrometer to increase the signal intensity of peptides and decrease the potential of
contaminating the ion source; methods include utilizing chlorinated solvents,

71

ZrO2-coated

silica beads, 72 and Langmuir monolayers 73 coupled with on-line desalting.
Overall, we expect that by optimizing quenching and digestion conditions, maintaining protein
native-like structure, removing detergent and lipid efficiently we can overcome the major
challenges of HDX-MS on soluble and membrane protein applications.

13

Irreversible Covalent Labeling MS
Irreversible covalent labeling MS, relying on the similar principle of HDX-MS, modifies the
solvent-exposed side chains compared with HDX-MS that examines the protein backbone. This
approach typically generates stable, irreversible modifications, facilitating to locate the labeling
site by a bottom-up approach. The workflow of covalent labeling MS starts from labeling
proteins to generate different types of modification with unique mass shifts. Then we digest the
modified proteins and submit the resulting peptide fragments to MS to locate the modification
sites.
A variety array of labeling reagents are now available that can be grouped into two categories:
nonspecific reagents that modify a wide variety of residues and specific reagents that only target
one or several specific residues.

74

Though many reviews that focus on irreversible covalent

labeling MS have become available,

74-78

only one review that mainly focuses on membrane

proteins appeared recently. 14
Nonspecific Covalent Labeling MS
Nonspecific covalent labeling, mostly depends on radical or other reactive species chemistry, can
simultaneously label a wide variety of amino acid residues.74 Hydroxyl radical, as one of the
most popular nonspecific reagents, can be generated via radiating water by synchrotron X-rays
(synchrotron-based hydroxyl radical footprinting, (HRF)),79 photolyzing hydrogen peroxide by
UV laser (fast photochemical oxidation of proteins (FPOP)),

80, 81

or chemically breaking

covalent bond of hydrogen peroxide by the Fenton reaction. 82, 83
HRF or FPOP typically occurs within µs or ms, avoiding labeling-induced conformational
change because the reaction time is too fast to allow proteins undergo structural changes.
14

81, 84

Although hydroxyl radicals react very fast with most of the amino acid residues, it confronts
three major problems: 1) over fifty different types of products complicate the MS analysis;

85

2)

three orders of magnitude of side chains’ reactivities towards hydroxyl radical 81 might introduce
artifactual conclusion between residue’s solvent accessibility and modification ratio; 3) the
silence to some specific residues, including Asp, Glu, Ser, Thr, Ala, and Gly, makes the MS
detection on those residues difficult or impossible to measure.

86

Hydroxyl radical also shows

limitations of labeling membrane proteins: the reaction causes lipid oxidation;

14

its hydrophilic

character restricts the access to the transmembrane domain.
To overcome these limitations, investigators have developed trifluoromethyl radicals
carbene

88-90

footprinters. Recently, Manzi

91

86, 87

and

and colleagues extended the nonspecific reagent

carbene, generated from photolysis of diazirine precursors by 350 nm UV laser, to map the
membrane protein’s transmembrane domain. Cheng 92 and colleagues generated iodine radical by
photolysis of the hydrophobic reagent perfluoroalkyl iodide using a 248 nm UV laser and applied
it to label the membrane-spanning region.
Specific Covalent Labeling MS
Specific covalent labeling that utilizes SN2 reaction to modify one or several specific residues of
a protein reduces the complication of data analysis. Generally, the method initiates the labeling
by adding the reagent instead of employing a laser to trigger the reaction. The detail and
applications of covalent labeling of soluble proteins was reviewed

74,77

— ethyl acetimidate

hydrochloride (ETAT) for Lys, 1‐ethyl‐3‐(3‐(dimethylamino)propyl)carbodiimide (EDC)
coupled with glycine ethyl ester (GEE) for Asp/Glu, methylgloxal (MG) for Arg, Nethylmaleimide (NEM) for Cys, diethylpyrocarbonate (DEPC) for nucleophilic residues, and
iodine radicals for Trp, Tyr, and His. 93
15

Besides experiencing similar technical challenges that are associated with nonspecific reagents,
specific reagents have one more challenge—keeping the protein’s integrity during the labeling.
In contrast to nonspecific reagents that achieve fast modification, specific reagents labeling
usually takes seconds to minutes at a slow reaction rate and this can introduce labeling-induced
conformational changes of a protein. To maintain the protein’s integrity, we need to optimize
reagent concentrations and labeling time. Additional biophysical tools, like circular dichroism
(CD), fluorescence spectroscopy or activity assays, are also needed to confirm whether any
significant structural perturbations occur on the protein. To monitor local structural changes with
higher confidence, Vachet’s group 94 used a plot of the extent of each residue’s modification as a
function of reagent concentration to measure the labeling kinetics.
HDX-MS and irreversible covalent labeling MS are complementary methods. HDX-MS can
primarily detect the protein’s conformational changes on the backbone at the peptide-level.
Covalent labeling MS allows us to achieve residue-level structural information by probing side
chains.

1.7.2 Cross-Linking Coupled with MS
Despite some common features in cross-linking and covalent labeling MS, they do differ in aim.
Cross-linking seeks to answer a question on how to determine subunit connectivity and
interactions of a protein complex. Covalent labeling addresses a question about how to map a
protein surface. Therefore, unlike “dead-end” modification by covalent labeling, cross-linking
introduces covalent bonds as “molecular ruler” between the functional groups of a protein to
identify and measure the distance between them. 95, 96 The measured distances provide constraint
information for further structure modeling. More details of the cross-linking MS have been
reviewed. 35
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Although the principle of cross-linking is straightforward, execution has challenges: 1) low
abundance of the cross-linked products requires lower detection limit; 97 2) relatively long crosslinked inter-peptides results in poor fragmentation, thus compromising the spatial resolution;

46

3) a variety of possible combinations of cross-linking and the massive data complicate data
analysis.
Several developments help address these issues. One means is to develop cross-linking reagents
with the following features: incorporating affinity tags and charge groups for separation and
enrichment, including isotope encoding, reporter groups, and cleavable sites for easier detection
and identification.

52, 98

Petrotchenko and colleagues

99

also employed non-specific enzyme

protein kinase K to generate very short stretches of cross-linked peptides, resulting in
unambiguous peptide identification on a protein.
Cross-linking MS complements covalent labeling—cross-linking MS imposes distant constraints
for a pair of residues, whereas covalent labeling MS detects protein’s solvent accessibility.

1.7.3 Limited Proteolysis Coupled with MS
The limited proteolysis method exposes proteins to a proteolytic enzyme within short, controlled
time to ensure that the protease first cleaves the most solvent accessible regions of a protein.

52

Based on this principle, we can deduce the outmost portions of the proteins that are enzymeaccessible, and detect conformational change by comparing different patterns of limited
proteolysis among various states of the proteins.
To determine the first cleavage fragment, investigators primarily utilize SDS-PAGE to separate
the cleavage products after 1-5 min exposure to the proteolytic enzyme; the shot exposure helps
observe the time-wise appearance of the cleaved fragments. Then, the first appeared fragments
17

will be in-gel digested and submitted to MS for peptide identification. Presently, a middle-down
approach becomes available, by coupling limited proteolysis with top-down proteomics, to
analyze large fragments from a partial digestion of a large protein.

100

A detailed understanding

of limited proteolysis MS was reviewed previously. 35

1.8 Metal-Binding Protein and Membrane Protein Studied
by Mass Spectrometry-Based Structural Proteomics
The applications of native MS,
77, 102-104

40, 41, 44, 47

HDX-MS,

54, 63, 101

and irreversible footprinting MS

14,

were thoroughly reviewed. In this section, we selected a few representative applications

of each above-mentioned strategies on metal-binding proteins and membrane proteins, and
detailed illustrated how these methods can separately or together solve the biological problems.

1.8.1 Native MS
Unlike previous work that needed to extensively remove detergent, Barrera and colleagues

105

pioneered in detecting intact membrane protein complexes by maintaining the detergent with
well above critical micelle concentration to protect interactions within the membrane proteins.
They demonstrated a strategy to determine the subunit stoichiometry, modifications to the
transmembrane, and ligand-binding of the membrane complexes heteromeric adenosine 5’triphosphate (ATP)-binding cassette transporter BtuC2D2, by electrospraying and dissociating a
n-dodecyl-β-D-maltoside (DDM) micellar solution that contain membrane protein complexes.
They first tested the method on five membrane protein complexes and expanded it to
characterize a well-known heteromeric transmembrane complex BtuC2D2, consisting of two
different subunits—transmembrane subunits (BtuC) and cytoplasmic nucleotide-binding subunits
(BtuD), and three types of intersubunit contacts. The authors observed DDM clusters at low m/z,
a broad distribution of heterogeneous assemblies containing over 100 DDM molecules at m/z
18

over 5000, and dissociated BtuD. The data imply that the complex was first protected by
detergent, it started to shake off the detergent when the collision energy increased, thus revealing
the distinct peaks of the intact tetramer. Further increasing of collision energy led to the
dissociation of BtuC and formation of a trimer. The unfolding pathway coincides with the
circular dichroism studies in aqueous DDM micelles that BtuD unfolds more readily than BtuC.
Applying appropriate activation conditions to disrupt interactions with the DDM, they observed
the intact membrane protein complexes with minimal dissociation, and this observation helped
confirm the overall stoichiometry of the complex as BtuC2D2 and determine the posttranslational
modification. The further gas-phase dissociation of the protein complexes revealed the
cooperativity of ATP binding provided by the dissociation causing the loss of transmembrane
domain and a mass shift corresponding to two ATP binding.
Adhikari and colleagues106 brought new understanding to Ca2+-binding innate immune protein
human calprotectin (hCP), a heterooligomer of two S100 proteins, S100A8 as α subunit and
S100A9 as β subunit, by using integrated MS-based approach, including native MS with HDXMS and PLIMSTEX. Investigators have obtained broad knowledge of the structure and function
of hCP, but questions of how Ca2+ triggers hCP oligomerization, increases the protease stability,
and enhances antimicrobial activity remain enigmatic. Integrating the data from three MS-based
structural proteomics methods, the authors detected four Ca2+-binding sites, determined the
binding stoichiometry between hCP and Ca2+ is 1:4, measured their binding affinities, and
assessed the ratio of protein to Ca2+ that cause the dimer-to-tetramer transition.
HDX-MS facilitated to identify the Ca2+-binding sites. Upon Ca2+ binding, the authors observed
a large reduction in HDX at N-terminal and C-terminal EF-hands, whereas regions that not
involved in Ca2+ binding show nearly invariant HDX behavior for bound and unbound states.
19

Projecting the averaged HDX of the two states revealed a global picture of how Ca2+ affect the
protein’s conformational change.
The previous HDX experiment laid the foundation for the application of PLIMSTEX that
indirectly detected the ligand binding whereby monitoring the HDX of protein that was titrated
with Ca2+. The resulting data upon fitting to models provided the binding affinities.
Finally, native MS helped follow the protein oligomerization from dimer to tetramer occurring in
the Ca2+ titration. It also afforded the molecular weight, stoichiometry, and relative stability of
the protein complex. With the increasing number of Ca2+ bound, the authors observed peaks that
represent up to 8 Ca2+ binding, which corroborates with the transition from heterodimer to
heterotetramer.

1.8.2 HDX-MS
An HDX application combined with native MS to provide comprehensive and quantitative
molecular information on metal-binding protein hCP was presented in the last section. Here, we
present an example of streamlining HDX to pave the way for future analysis of G-protein
coupled receptor (GPCR) family members and other integral membrane proteins. To enable
HDX to characterize well-known GPCRs, Zhang 107 and colleagues modified the HDX workflow
to characterize the binding of integral membrane protein β2-adrenergic G-protein coupled
receptor (β2AR), regulating cellular processes by transforming external stimuli to intracellular
signals, with the inverse agonist carazolol.
Problems peculiar to membrane proteins, like sensitivity to pH, propensity to aggregate, high risk
of contaminating the mass spectrometer, and suppressing ionization owing to the detergent
medium, hamper the characterization by HDX-MS. The study of β2AR becomes further
20

complicated in HDX analysis owing to its heavy post-translational modifications. To improve
the digestion efficiency, the authors optimized the detergent, reductant, HPLC parameters, mass
spectrometry settings, and protein modifications (removing glycosylation by PNGase F). The
authors found that the use of DDM in quench solution not only improved the sequence coverage,
but also aided the solubilization and stabilization of the membrane protein. Optimizing these
experimental conditions, the authors obtained over 89% sequence coverage, enabling to generate
a comprehensive structural picture of β2AR.
Mapping the deuterium uptake difference on the 3D structure of carazolol-bound β2AR, the
authors observed significant protection of the transmembrane domain, whereas the linkages
between transmembrane helices showed moderate exchange. The result helped the authors to
determine the more dynamic regions of the membrane protein and laid the foundation for future
analysis of integral membrane proteins.

1.8.3 Irreversible Covalent Labeling (Hydroxyl Radical Footprinting)
Coupled with MS
Lim

108

and colleagues demonstrated a promising approach for identifying critical residues that

are located in the coordination environment of the metal-binding proteins. They utilized
hydroxyl radicals generated by metal catalysis to identify the copper binding-sites in the metalbinding proteins angiotensin I and azurin. Residues that coordinate with metal are expected to be
protected the oxidative labeling, whereas those not involved in binding will show similar
modification between copper-free and copper-bound states. The results show that this method
has potential to apply on other metalloproteins.
Pan

109

and colleagues illustrated the viability of hydroxyl radicals labeling for characterizing

membrane proteins under different conditions. They expanded hydroxyl radicals generated by a
21

laser with analysis by MS to gain insight of bacteriorhodopsin (BR), the main component in the
purple membrane of the archaebacterium Halobacterium salinarum, under partially denatured
conditions. The oxidative labeling reveals that: when exposed to the acidic buffer, the BR
retained the comparable labeling pattern as the native state, suggesting that low pH has minimal
perturbation on BR’s high-order structure. When treated with SDS or thermal denaturation, the
BR unfolded helices A and D. Although the extensive labeling on Met at solvent-exposed loop
helped distinguish the extramembrane region and transmembrane domain, the authors still had
problems obtaining structural information of solvent-inaccessible transmembrane domain.
In contrast to previous studies, Angel and colleagues

110

extensively labeled the transmembrane

domain by using oxidative labeling. The reason is that they aimed to locate the structural waters,
indispensable for functions of the GPCR, in the transmembrane domain by irradiating them to
generate free radicals in situ.
These applications demonstrated that each MS-based structural method has its advantages and
limitations. Therefore, we need to integrate these methods to understand fully the protein
structures and functions. When expanding MS-based footprinting to membrane protein studies,
we need to further develop novel reagents with appropriate hydrophobicity that can diffuse into
the hydrophobic transmembrane domain (vide infra).
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Chapter 2: Isotope-Encoded Benzhydrazide
for Metal-Binding Protein Footprinting
This chapter is based on a published article: Chunyang Guo, Ming Cheng, and Michael L.
Gross. “Protein-metal-ion interactions studied by mass spectrometry-based footprinting with
isotope-encoded benzhydrazide.” Anal Chem 2018, 91 (2), 1416-1423.

2.1 Abstract
Metal ions, usually bound by various amino-acid side chains in proteins, play multiple roles in
protein folding, conformational change, and cellular communication. Ca(II) and Mg(II),
abundant among biologically relevant cations, execute their cellular functions associated with the
conformational change of bound proteins; they bind with proteins where carboxylic acid residues
are dominant ligands. To develop mass spectrometry for mapping protein binding-sites, we
implemented a new carboxyl group footprinter, benzhydrazide, and incorporated isotopes for
more accurate quantification. In this chapter, we describe a method that uses carbodiimide
chemistry

to

footprint

carboxylic

residues,

whereby

1-ethyl-3-(3-(dimethylamino)

propyl)carbodiimide activates a carboxyl group followed by nucleophilic attack by
benzhydrazide forming a stable labeled product. We tested the effectiveness of isotope-encoded
benzhydrazide by studying Ca2+ and Mg2+ binding of calmodulin—an EF-hand protein. The
footprinting results illustrate that the four active sites for metal-ion binding (EF hands I, II, III,
and IV) and the linker region (peptide 78−86) undergo conformational changes upon Ca(II) and
Mg(II) binding, respectively. The outcome corroborates with previously reported results and
protein’s 3D structure, thereby validating a new reagent that is more reactive and discriminating

30

for specific amino-acid protein footprinting. This reagent sheds the light for locating metalbinding sites of other metal-binding proteins.

2.2 Introduction
Metal ions bind via functional groups termed ligands that donate lone pairs to the metal ions to
catalyze a variety of biochemical reactions or stabilize the protein structures.

1

Based on

properties of coordinated metals, we classify two types of metals that interact with proteins: 1)
borderline/soft cations (e.g., Zn(II), Fe(II), and Cu(II)) that coordinate with nitrogen- and sulfurcontaining groups found in His and Cys, and 2) hard cations (e.g., Ca(II) and Mg(II)) that prefer
to coordinate with oxygen ligands (e.g., Asp and Glu). We have known metals interact with
protein to carry out cellular functions, but the knowledge is, of the location of the metal-binding
sites and the binding characteristics that help thoroughly understand the functional mechanisms
of metal-binding proteins, still limited.
We focus on developing MS-based structural proteomics method to characterize calmodulin
(CaM) that bind with hard metal cations Ca(II) and Mg(II), ubiquitous in metalloproteins that
chelate with carboxylic residues. MS-based structural proteomics that can overcome challenges
associated with high-resolution biophysical tools has been discussed in Chapter 1. Scientists
have widely applied hydrogen-deuterium exchange MS (HDX-MS) to characterize protein
structure; 2-5 the method can also be extended to monitor the conformational changes of proteins
upon Ca2+ binding and even measure the binding constants by an approach termed protein-ligand
interactions by MS, titration, and HD exchange (PLIMSTEX).

6

However, HDX-MS monitors

the change on the amide bond around the metal-binding site, instead of direct detecting the
change of key binding residues.
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An alternative method irreversible covalent labeling can help overcome this challenge. We
described the principles, advantages and limitations, and applications of this method in Chapter
1. Among all the specific covalent labeling methods, carbodiimide chemistry provides the most
versatile method for labeling carboxylic acids. Earlier, Zhang

7

employed glycine ethyl ester

(GEE) coupled with 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride (EDC) to
footprint Asp and Glu residues in CaM and thus located the metal-binding sites. Later, he and
colleagues incorporated three isotopes in GEE to reduce the sample runs and MS analysis, and
improve the accuracy of quantification.

8

Presently, GEE labeling has been expanded to study

membrane proteins, therapeutic proteins, and intrinsically disordered proteins.

9-15

Nevertheless,

the relatively low reactivity (need 20,000 equiv with respect to the protein), hydrolysable
labeling product, and limited isotope-encoding opportunity restrict GEE’s further application.
Our goal was to develop a novel isotope-encoded carboxylic acid footprinter that alleviate GEE’s
limitations to detect the metal-binding sites of CaM.
Because only a limited number of isotopic footprinters are commercially available, let alone the
isotope-encoded carboxyl footprinters. In this chapter, we developed and synthesized a new
isotopic labeling reagent benzhydrazide (BHD) (Figure 2.1), in the presence of carbodiimide
compound (EDC), inspired by Leitner.

16

The method starts from activating carboxylic acid

residues by EDC first, followed by the nucleophilic modifying reagent BHD attacking. The
reactive BHD labeling requires less amount of reagent to measure the metal-binding sites of
CaM, which decreases the potential to perturb protein structure. The labeling avoids the
hydrolysis of the modified product and thus simplifies the reaction and data analysis. Further,
the ability of incorporating five deuteriums in BHD allows us to utilize stable-isotope encoding
method 17 to further improve the MS quantification (Figure 2.1).
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Figure 2.1 Chemical strucutures of BHD and d5-BHD.

2.3 Materials and Methods
2.3.1 General
All chemicals unless otherwise stated were received from Sigma-Aldrich (St. Louis, MO)
without further purification. Tris base, HEPES buffer (pH 7.5), urea, water, formic acid, glycine
ethyl ester hydrochloride (GEE), calcium chloride, magnesium chloride, ammonium acetate,
1,1’-carbonyldiimidazole, benzoic acid, benzoic acid-2,3,4,5,6-d5, tetrahydrofuran (THF),
hydrazine hydrate solution (78−82%), Z-Glu-OMe, and thin-layer chromatography supplies
(TLC, silica gel 60 F254). N-Benzyloxycarbonyl-L-aspartic acid 1-methyl ester was obtained
from Alfa Aesar (Lancashire, U.K.). Sartorius Vivaspin 500 μL centrifugal concentrators were
purchased from Sartorius Corporation (Goettingen, Germany). The protein bovine calmodulin
(CaM) was from Ocean Biologics (Seattle, WA). The 1-ethyl-3-(3- (dimethylamino)
propyl)carbodiimide hydrochloride (EDC), trypsin, and Zeba spin desalting columns (7K
MWCO) were from Thermo Scientific (Rockford, IL). Cyclo(Arg-Gly-Asp-DPhe-Glu) was from
Peptides International, Inc. (Louisville, KY).

2.3.2 Synthesis and Characterization of Benzhydrazide and d5-Benzhydrazide
In 100 mL reaction flask, 1,1’-carbonyldiimidazole (1.73 g, 10.6 mmol) was added to a solution
of benzoic acid (1.00 g, 8.19 mmol) dissolved in THF (15 mL). After stirring at 25 °C for 3 h,
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the mixture was added dropwise to the hydrazine hydrate solution (78-82%, 1.23 g, 24.6 mmol)
in 6 mL THF over 45 min. The reaction went complete overnight at 25 °C, as monitored by TLC.
Solvents were evaporated in vacuum to obtain a crude white product that was isolated and
purified by silica gel column chromatography (hexane:ethyl acetate = 1:1) to give the
benzhydrazide as a white solid (1.03 g, 93% yield). d5-Benzhydrazide was synthesized by using
an identical procedure, giving the product as a white solid (1.00 g, 87% yield). High resolution
mass spectra (HRMS) were recorded with a Bruker MaXis QToF (ESI). HRMS (ESI) m/z calcd.
for protonated BHD (C7H8N2OH+): 137.0715. Found: 137.0714. HRMS (ESI) m/z calcd. for d5BHD (C7H3D5N2OH+): 142.1029. Found: 142.1028.

2.3.3 Preparation of Protected Amino Acids/Peptide/Protein Stock Solution
All protected amino acids (Z-Glu-OMe and N-Benzyloxycarbonyl-L-aspartic acid 1-methyl ester)
and cyclic peptide stock solutions of 100 μM concentration were prepared in 10 mM HEPES
buffer. Ca2+-free CaM (50 μM) was prepared by washing three times with HEPES buffer at 15,
000 (×g) speed using Vivaspin centrifugal concentrators, whereas Ca2+-bound CaM was prepared
by incubating 50 μM CaM with 500 μM CaCl2 overnight at 25 °C. Similarly, Mg2+-bound CaM
was prepared by incubating 50 μM CaM with 500 μM MgCl2 overnight at 25 °C. The
concentration of CaM in 10 mM HEPES buffer (pH 7.5) was determined by using UV
absorbance (molar absorptivity of 2,980 L mol−1 cm−1 at 280 nm) with a NanoDrop
spectrophotometer (Thermo Scientific, Waltham, MA).

2.3.4 Carboxyl Group Modification
The final concentrations of protected amino acids, peptide, or protein for all reactions were
adjusted to 10 μM. For protected amino acids, the labeling was initiated by adding BHD and
EDC to give final concentrations of 20 mM and 500 μM, respectively. The protected amino acid
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modification was quenched after 20 min by adding 20 μL ammonium acetate (1 M). For cyclic
peptides, the labeling followed the same procedure as protected amino acids, except the labeling
was quenched after 24 h. Experiments with CaM were performed in triplicate by using 20 mM
BHD and 500 μM EDC, identical to the concentration used for cyclic peptide labeling. After 5
min of reaction at 37 °C, the solution was quenched by removing the reagents by using a Zeba
spin desalting column according to the manufacturer’s protocol.

2.3.5 Protein Digestion
After desalting, the filtrate was evaporated to dryness in a vacuum centrifuge. The pellets were
dissolved with 50 μL water to make an equal volume of protein. Aliquots of 10 μL filtrate of
BHD and d5-BHD were combined at 1:1 ratio (v/v) and dried in vacuum (the dry sample can be
stored in a freezer at -80 °C for months). Prior to analysis, the protein mixture pellet was
denatured with urea (8 M, 5 μL) at 37 °C for 30 min, followed by adding 45 μL Tris buffer (pH
8.5). Protein samples were then digested with trypsin at a protease:protein ratio of 1:20 (w/w) at
37 °C overnight. Pure formic acid (1 μL) was added to stop the digestion.

2.3.6 Solvent Accessible Surface Area (SASA) Calculation
PDB files of CaM (PDB: 1CFC) and Ca2+-bound CaM (PDB: 1CLL) were sent to GETAREA
(http://curie.utmb.edu/getarea.html) to calculate individual side chain’s SASA.

2.3.7 Mass Spectrometry
All mass spectra for intact proteins were acquired on a Bruker MaXis Q-TOF (Bremen,
Germany) in the positive-ion mode, as was reported previously. 18
For proteolytic peptides, digests were analyzed on a Q Exactive Plus hybrid quadrupole orbitrap
mass spectrometer coupled with a Nanospray Flex ion source (Thermo Fisher, Santa Clara, CA).
A C18 column was custom fabricated with an integrated emitter (75 μm × 150 mm, 1.8 μm, 100
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Å). The gradient was from 2.0% solvent B (80% acetonitrile, 0.1%formic acid) to 20% solvent B
over 55 min, then to 50% solvent B over 25 min, and finally to 90% solvent B for 10 min
followed by a 15 min re-equilibration step. The 15 most abundant molecular ions were
automatically chosen for fragmentation (DDA) by using the mass spectrometer scanned from m/z
380-2200 at a resolving power (RP) of 70 K (at m/z 200) throughout the chromatography.
Precursor ions were isolated in the quadrupole with an isolation window of 2.0 m/z and
fragmented with higher-energy collisional dissociation (HCD) with a normalized collision
energy (NCE) of 32%. The automatic gain control (AGC) targets were 5 × 105 for MS and 5 ×
104 for MS/MS acquisitions. Maximum injection times (maxIT) were 200 ms for MS and 100 ms
for MS/MS.

2.3.8 Data Analysis
The LC-MS/MS data were searched for unmodified and modified CaM tryptic peptides by using
Byonic Software (Protein Metrics, San Carlos, CA). All BHD and d5-BHD modifications on Asp
and Glu were added as modifications to the database. The parameters were: 10 ppm precursor
mass tolerance, 60 ppm fragment mass tolerance, and CID/HCD fragmentation. Modificationsites were validated by manually checking product-ion spectra and were double-checked with
Thermo Xcalibur (a custom program from Thermo Fisher, Santa Clara, CA). The modification
ratio was calculated based on the following equation by extracting ion chromatograms (EIC):
Modification % = (∑modified peptide)/(∑modified peptide +∑unmodified peptide) (2.1)

2.4 Results and Discussion
Besides accurate detecting the metal-binding sites, stable isotopic BHD labeling improves
quantification. Isotope-encoded BHD satisfies certain criteria for a good isotopic footprinter: 1)
isotope-encoding maintains the chemical reactivity of footprinter; 2) analytes and their isotopic
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analogs (nearly) coelute from the LC; in this way, a pair of isotope-labeled analytes would
experience the same ionization efficiency during MS analysis, which lays the foundation of
accurate quantification; 3) separating the peaks of the “light and heavy” analogs, over a range of
m/z from 400−2000, necessitates sufficient mass difference between two isotopically encoded
adducts. Therefore, taking advantage of isotope-encoded BHD to normalize the MS intensity of
analytes to their isotopic analogs effectively compensates for solvent effects, variable ion
suppression from other coeluting analytes, and experimental variations accompanying sample
preparation, injection, and instrument setup.

2.4.1 Test the Reagent’s Chemical Reactivity on N- and C-Term Protected
Asp and Glu
To demonstrate the feasibility of the new reagents, we performed three main experiments
focusing on BHD’s labeling performance on amino acid, peptide, and protein, respectively. The
first experiment tested the intrinsic chemical reactivity on Asp and Glu by measuring the relative
labeling efficiency on N- and C-term protected aspartic acid and glutamic acid (Figure 2.2).
Under the same labeling conditions, Asp and Glu had comparable modification extent, with an
adjusted mean difference of 0.1% (Figure 2.3).

Figure 2.2 Chemical structures of N- and C-term protected D and E.
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Figure 2.3 Modification extent on N-term- and C-term-protected D and E.

2.4.2 Test the Reagent’s Chemical Reactivity on Cyclic Peptide
The second experiment was to test whether “light” and “heavy” exhibit similar chemical
reactivity on a cyclic peptide cyclo(RGDFE) (Figure 2.4a). Not that linear peptide cannot report
the reagent labeling efficiency, but that cyclic peptide without secondary structure and no N- or
C-termini will simplify the reaction. Data were summarized as means ± SD. We integrated
unmodified (black), BHD- (light blue), and d5-BHD (dark blue) labeled cyclic peptides and
found that 43.2% for “light” and 44.6% for “heavy” labeling; therefore, the presence of isotopes
in BHD maintained the reactivity on the carboxylic residues in cyclo(RGDFE).
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Figure 2.4 Chromatograms and MS/MS spectra of isotope-encoded BHD modified cyclo(RGDFE). a) Extracted ion
chromatograms (EIC) for unmodified (black), BHD- (light blue) and d5-BHD modified (dark blue) cyclo(RGDFE),
product-ion (MS/MS) spectrum for BHD- b), and d5-BHD- c) modified cyclo(RGDFE). (Orange circle: loss of NH3,
blue circle: loss of H2O, yellow square: addition 118.0524 or 123.0845 mass unit, green square: addition of
118.0524 or 123.0845 mass unit and loss of H 2O, pink square: addition of 118.0524 or 123.0845 mass unit and loss
of NH3.)

To validate the peptide assignments, we manually assigned peaks in the product-ion spectra
(MS/MS) for the BHD- and d5-BHD modified cyclo(RGDFE), confirming that the modification
occurred at both Asp and Glu (Figure 2.4 b and c). The detail of the nomenclature for cyclic
peptides can be found in previous reports.

19, 20

In addition, we did not find di-labeled peptide.

The labeling results confirm that reagents modify both Asp and Glu even when they are
adjoining in the cyclic peptide (cRGDFE) (Figure 2.4a). This feature enables isotope-encoded
BHD to modify all carboxylic residues in a binding pocket rather than react with one and keep
“silent” to another.
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In our case, we substituted hydrogen with deuterium, due to the difference in atom’s size,

21, 22

which leads to differences in the binding interactions (van der Waals interactions) with the
stationary phase—protiated compounds bind to hydrophobic stationary phase more strongly than
their deuterated counterparts.

21

We then determined whether d5-BHD show any isotope effect

during the LC separation. When comparing the retention time of BHD- and d5-BHD modified
peptide (Figure 2.4a), we found a small isotope effect that d5-BHD modified peptides eluted
approximately 11 s after the BHD-modified counterpart.

2.4.3 Test the Reagent’s Chemical Reactivity on Protein

Figure 2.5 BHD modification ratio on CaM under various reagent’s concentrations.

We then moved along to the third experiment to test BHD’s reactivity on protein—calmodulin
(CaM), a highly conserved, secondary messenger protein, is ubiquitous in eukaryotic cells; it
contains four highly conserved motifs, referred to as “EF hands”, which show a typical
helix−loop−helix motif. We optimized the BHD labeling concentration by fixing the
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concentration of EDC at 500 µM—50-fold excess relative to CaM. Because each CaM
comprises 37 Asp and Glu, we use a little bit excess of EDC to ensure that all Asp and Glu
residues on the protein have a chance to be activated. Over the course of BHD labeling from 5 to
20 mM, the modification extent of CaM increased from 43% to 65% (Figure 2.5). With the
BHD’s concentration further increased, the modification extent almost remained the same,
probably because EDC no longer acted as the limiting reagent. Thus, we chose 20 mM as BHD’s
optimum concentration.

Figure 2.6 The BHD modification state ion counts are modeled for the spectrum (figure courtesy of Don Rempel).

To further test whether BHD modification maintains protein structure, we tested whether the
footprinting data follow a Poisson distribution, which expresses the probability of a number of
events occurring in a given amount of time, distance, area, or volume. These events should occur
randomly and independently. Based on these rules, we can deduce if BHD modification induces
significant conformational change by testing whether each modification site is independent of
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other modifications.

23

If BHD modification does not significantly alter protein structure, the

distribution of the modified product with +0, +118, +236 Da… additions should be near Poisson
distribution. Overall, the distribution of BHD modified CaM nearly fits the Poisson distribution
(Figure 2.6), suggesting that BHD can extensively label CaM without significantly perturbing its
conformational change.
We then tested the relative reactivity of “light” and “heavy” BHD on CaM. Similar to the result
on cyclo(RGDFE), we found that “light” and “heavy” BHD showed nearly identical
modification extents for the intact CaM protein. At the same labeling conditions, CaM
experienced around 67%±3% BHD modification, compared with around 25% GEE labeling,
providing that BHD is more reactive (Figure 2.7).

Figure 2.7 Mass spectra of modified CaM at +15 charge state: a) control: Ca2+-free CaM, Ca2+-free CaM labeled by
b) GEE, c) BHD, and d) d5-BHD (25 °C, 5 min).
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2.4.4 Applying Isotope-Encoded BHD to Locate Ca2+ Binding Sites
After evaluating the feasibility of the isotope-encoded BHD, we were ready to test whether the
new footprinters can report the metal-binding sites of CaM. The “light” and “heavy” labeled the
two different states of CaM; Ca-free CaM was labeled by d5-BHD in one Eppendorf tube and
Ca-bound CaM was labeled by d0-BHD in another tube (Figure 2.8). Following the footprinting,
the tube contents were combined in a 1:1 ratio prior to trypsin digestion and LC-MS/MS analysis.
In this way, we could maintain all experimental conditions (e.g., protein digestion, MS analysis)
nearly identical for both “light” and “heavy” labeled samples following protein modification.

Figure 2.8 Workflow for isotope-encoded BHD labeling.

Data processing show 100% sequencing coverage of CaM and nearly 73% carboxyl groups
undergo BHD modification (37 carboxyl groups in total). We took peptide 78-86 for example to
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present data analysis. Integrating the EICs, we calculated peptide 78-86 underwent the d5-BHD
(+123.0845) and d0-BHD (+118.0531) modifications by around 17.5% and 5.2%, respectively
(Figure 2.9a). Besides assisting the identification of the modified peptides, this chromatographic
pattern facilitates to separate the isomeric peptides with modifications on different residues. The
MS/MS spectra present an example that the modification occurred on E7 of the peptide (Figure
2.9b and c). When comparing the retention time, we observed, as before, a small isotope effect
(Figure 2.9a) that d5-BHD modified peptide 78-86 eluted 15.6 s earlier than its d0-BHDmodified counterparts, consistent with the previously reported effect of deuteration. 21 In addition,
we found that the labeled peptides became more hydrophobic and eluted approximately 14 min
later than their unmodified counterparts (Figure 2.9a and 2.10).

Figure 2.9 Chromatograms and MS/MS spectra of isotope-encoded BHD modified peptide 78-86. a) EIC for BHD(light blue) and d5-BHD- (dark blue) modified peptide 78−86, b) product ion (MS/MS) spectrum for peptide 78−86:
unique mass shift of b) 123.0845 Da, and c) 118.0531 Da corroborates with d5-BHD and BHD modification on E7.
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Figure 2.10 EIC of unmodified peptide 78-86.

Taken together, we found that eight regions of the protein underwent large conformational
changes with modification extent difference over 50% and p-values

24

less than 0.01. (Figure

2.11), consistent with Ca2+-induced structural transitions that dramatically alter the molecular
surface of CaM.
We projected our data on the high-resolution NMR and X-ray structures of CaM and Ca2+-bound
CaM. CaM binds Ca2+ at four, nonidentical sites that contain the EF-hand structural motif, two in
the N-domain (EF-1 and EF-2) and two in the C- domain (EF-3 and EF-4). Each hand contains
an acidic, Ca2+-coordinating loop, or “EF-loop” where Ca2+ chelates with seven oxygens from
six residues in a pentagonal bipyramidal fashion. 25, 26 EF-1 chelates Ca2+ with ligands D20, D22,
D24, and E31 from peptide 14−21, 22−30, and 31−37 (Figure 2.12a and f). For this binding-site,
the reagent extraordinarily discriminated the carboxylates of Ca2+-bound CaM with little
modification (Figure 2.11). In EF-2 region, Asp and Glu nearly completely lost their chemical
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reactivity (Figure 2.12 b and g), leading the modification extent difference between the two
states of the CaM reached 97% (Figure 2.11).

Figure 2.11 Labeling results of isotope-encoded BHD on Ca2+-free CaM (dark blue) and Ca2+-bound CaM (light
blue).

As pointed out earlier, the binding of Ca2+ to the EF hands induces a dramatic change of the
linker region (peptide 76-86 and 78-86), changing from a flexible loop (Figure 2.12c) to a rigid
α-helix (Figure 2.12h). Although the conformation of this linker region was under debate that
the formation of the α- helical conformation is a crystallization artifact,

27

many studies

28

reported that the Ca2+ binding does induce domain opening in CaM, indicating the linker region
becomes extended and more rigid than in the apo-CaM. The plasticity of the linker region in
Ca2+-bound CaM allows EF-hand domains to orient to various directions with respect to each
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other. 29 Our footprinting results also reveal a significant modification change, evidenced by two
overlapping peptides that show approximately 70% modification difference (Figure 2.11). We
also observed the same labeling trend as in EF-3 and EF-4 region (Figure 2.11, 2.12d, e, i and j).

Figure 2.12 3D structure of Ca2+-free CaM from the average NMR structure (PDB ID, 1CFD) and Ca 2+-bound CaM
from the X-ray crystal structure (PDB, 1CLL). (Asp and Glu shown as sticks.) Region a) 20-31, b) 56-67, c) 78-86,
d) 93-104, e) 129-140 in Ca2+-free CaM. Region f) 20-31, g) 56-67, h) 78-86, i) 93-104, j) 129-140 in Ca2+-bound
CaM (gray sphere represents the metal ion).

To investigate whether the labeling results agree with changes in SASA, we compared the
residue-level quantification with the SASA of CaM (Figure 2.13). The D and E residues at the
EF hands significantly decreased modification upon Ca2+ binding, whereas those locate at nonbinding sites showed moderate change of modification, corroborating well with the changing
trend of SASA on average. Nevertheless, the decreased modification extent of E82/E83/E84
showed discrepancy with the theoretical increasing SASAs, which may attribute to the reaction
in this region not only depends on solvent accessibility but also on stereochemistry and
microenvironment.
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Compared with the previous GEE study, 7 BHD with 10% amount of GEE can report the metalbinding sites. The BHD’s higher reactivity compared with GEE relates to that the presence of
adjacent nitrogen atoms with nonbonding electron pairs to increases the terminal amine group’s
nucleophilicity, called alpha effect. 30

Figure 2.13 The modification extent a) and calculated SASA b) of D and E residues of Ca2+-free and Ca2+-bound
CaM.

2.4.5 Applying Isotope-Encoded BHD to Locate Mg2+ Binding Sites
We further expanded the approach to study Mg2+-bound CaM. Divalent Mg, a “hard” ion, prefers
to coordinate with oxygen containing ligands. Microcalorimetric studies indicated four identical
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Mg2+-binding sites partially overlap with the Ca2+-binding sites in CaM; however, experimental
data from flow dialysis, NMR, and fluorescence illustrated that Mg2+ shares same binding sites
with Ca2+.

31

Only recently, X-ray crystallography revealed N-terminal structure of Mg2+-bound

CaM-binding sites that Mg2+ shares same binding sites with Ca2+.

25

In contrast to the well-

characterized Ca2+-bound structure, the full high-resolution structure of Mg2+-bound CaM
remains unknown.

Figure 2.14 Labeling results of isotope-encoded BHD on Mg2+-free CaM (dark blue) and Mg2+-bound CaM (light
blue).

Although previous reports disagreed on details, they agreed with that Mg2+ indeed binds to CaM,
likely at the calcium sites. Compared with Ca2+-bound CaM, same regions that showed
statistically significant modification extent difference emerged in Mg2+-bound CaM (Figure
2.14). Thus, our results support the conclusion

26, 31, 32
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that the binding-site of Mg2+ resembles

that of Ca2+. Mapping the footprinting results of EF-1 on the 3D structure, we found that that
E31 underwent 0.008% BHD modification in Mg2+-bound CaM, but undetectable modification
in Ca2+-bound CaM, which coincides with the geometry that pentagonal bipyramid coordination
for Ca2+ binding to but octahedrally coordinated Mg2+ unbinds to Glu12 at the EF-hand (Figure
2.15a). Furthermore, Mg2+ induced less modification extent differences compared to that of
Ca2+-binding (89% for Mg2+- vs. ∼100% for Ca2+- bound ones), confirming weaker binding for
Mg2+ that reported previously.

28, 32-34

The result may be due to the smaller ionic radius of Mg2+

than that of Ca2+ to allow some carboxylic acid residues to coordinate with Mg2+ (72 Å for Mg2+
vs. 106 Å for Ca2+), thus eliminating any large differences in the reaction of BHD with Mg2+
binding.

35

An alternative explanation of the result relates to the enthalpy changes: the enthalpy

changes upon Ca2+ binding being exothermic, whereas endothermic, and thus unfavorable, for
Mg2+ binding to CaM. 33 We also observed the linker region, EF-3, and EF-4 showed less change
than did Ca2+-bound CaM.

Figure 2.15 3D structure of Mg2+-bound CaM (PDB ID, 3UCW). Region a) 20−31 and b) 55−67 (gray sphere
represents the metal ion, red sphere represents water molecule).
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For EF-2 region, Mg2+ showed a very different coordination pattern. From the X-ray structure,
Mg2+ coordinates with two oxygens from T62 and a backbone carbonyl group (Figure 2.15b).
The remaining four coordinating positions, occupied by four water molecules that form strong
hydrogen bonds with D58 and E67, allow Asp and Glu residues to gain some protection. In other
words, Mg2+ directly binds to first-shell water molecules and indirectly bind to D58 and E67 (the
binding is called a second-shell ligand interaction). Our method measured almost same
modification extent difference in peptide 38-74 with that for Ca2+-CaM, even though Mg2+
indirectly interacts with the nearby carboxylic residues. The footprinting data remind us to
develop a more sensitive reagent if we want to resolve the pattern between first- and second-shell
ligand binding.
In summary, four EF hands and the linker region of Mg2+-bound CaM undergo conformational
changes, but Mg2+ induces less significant conformation change than does Ca2+.

2.5 Conclusions
We developed the novel isotope-encoded BHD starting from synthesis, over evaluation on amino
acid, cyclic peptide, and protein, to application on Ca2+ and Mg2+-bound CaM to readily identify
the metal-binding sites. Instead of monitoring the changes on residues around the binding sites of
hard metals, isotope-encoded BHD can directly footprint carboxyl groups at the binding site to
reveal the conformational change. Footprinting results reveal that Mg2+ induces same regions
undergo large conformational change as does Ca2+ in CaM, but less significant.
This isotope-encoded BHD has several advantages: 1) straightforward two-step synthesis of
BHD, starting from commercial-available and inexpensive chemicals; 2) high chemical reactivity
and stable modified product; 3) successful incorporation of five deuteriums to improve the
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accuracy of quantification. However, we observed the reagent has small isotope effect and
cannot differentiate first- and second-shell ligand interactions, which inspires us to incorporate
isotopes like

15

N or

13

C and develop a more discriminating reagent. In the future, we wish to

expand this new footprinting approach to other hard metal-ion binding proteins and, via a
titration protocol, to test its ability to determine metal-binding affinity.
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Chapter 3: An Integrated MS-Based
Platform for Immune Protein Siderocalin
Characterization
This chapter is based on a published article: Chunyang Guo, Lindsey K. Steinberg, Ming
Cheng, Jong Hee Song, Jeffrey P. Henderson, and Michael L. Gross “Site-specific siderocalin
binding to ferric and ferric-free enterobactin as revealed by mass spectrometry.” ACS Chem Biol
2020, 15(5), 1154-1160.

3.1 Abstract
Both host and pathogen competitively manipulate coordination environments during bacterial
infections. Human cells release the innate immune protein siderocalin (Scn, also known as
lipocalin-2/Lcn2, neutrophil gelatinase-associated lipocalin/NGAL) that can inhibit bacterial
growth by sequestering iron in a ferric complex with enterobactin (Ent), the ubiquitous E. coli
siderophore. Pathogenic E. coli use the virulence-associated esterase IroE to linearize the Ent
cyclic trilactone to linear enterobactin (lin-Ent). Examining Scn interactions with enterobactinbased ligands frustrate traditional structural approaches; therefore, we implemented an integrated
MS-based platform to circumvent the associated limitations. We characterized lin-Ent
interactions with Scn by native mass spectrometry (MS), hydrogen-deuterium exchange (HDX),
and Lys/Arg specific covalent footprinting. These approaches support 1:1 binding of both
Fe(III)-lin-Ent to Scn and iron-free lin-Ent to Scn. Both ferric and nonferric lin-Ent localize to all
three pockets of the Scn calyx, consistent with Scn captures of lin-Ent both before and after
Fe(III) chelation. These findings raise the possibility that Scn neutralizes both siderophores and
iron-bound siderophore during infections.
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3.2 Introduction
In this chapter, we study iron-binding protein siderocalin (Scn) that we mentioned in the
introduction. During infections, pathogenic bacteria must often overcome substantial
thermodynamic barriers to obtain iron from host reservoirs. This competition between host and
pathogen represents a robust tug-of-war over transition metal iron ions (Figure 3.1). Many
bacterial pathogens activate the biosynthesis of siderophores,

1-3

low molecular-weight iron

chelators that scavenge iron for bacterial use. In response, host cells secrete Scn (also known as
lipocalin-2/Lcn2, neutrophil gelatinase-associated lipocalin/NGAL, or 24p3) to hinder iron
acquisition by the pathogen.

4-6

Unlike the canonical iron-binding proteins that chelate iron ions

directly, Scn specifically binds ferric ions chelated with various catecholates that are either
pathogen-derived siderophores

1

or host-derived metabolites.

4-7

The E. coli siderophore

enterobactin (Ent) (Figure 3.2a), a prototypical Scn ligand, was recently detected alongside Scn
in the urine of patients with E. coli urinary tract infections (UTIs). 7

Figure 3.1 The tug-of-war between host cell and bacteria over iron (reused with permission from reference 3).
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High quality X-ray crystal structure analyses of Scn reveal an eight-stranded antiparallel β-barrel
core, defined as the calyx, that binds with ferric-catecholate complexes through positively
charged side chains of three residues (R81, K125, and K134).

2, 8-11

These three residues form a

distinctive hybrid electrostatic/cation-π interaction network with the delocalized π electrons of
nearby ligand catechol functional groups. Additional interactions including van der Waals and
hydrogen bonding are contributed by residues lining the calyx. 1

Figure 3.2 Chemical structures of enterobactin (Ent) a) and linear enterobactin (lin-Ent) b).

Recent studies utilized several biophysical tools to define structural interactions between Scn and
potential ligands; however, methods like optical and fluorescence spectroscopies

1, 5

only report

global structure principally based on distinctive optical and fluorescence quenching signals upon
transition metal binding. Although X-ray crystallography has provided detailed Scn structural
data, the chemical instability of Ent during co-crystallization has been an irksome barrier to
describe these complexes.

4, 8

The high-spin Fe(III) in the calyx also limits NMR to analyze Scn

interactions. 12
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To circumvent these problems, we turned to fast, sensitive, and high-throughput mass
spectrometry (MS)-based structural proteomics approaches that complement the available, high
quality X-ray crystallographic structures. In this chapter, we describe the application of MSbased structural proteomics to interrogate the interactions between Ent and Scn in intact, bound
ferric and aferric complexes. Specifically, we focus on Scn interactions with linear Ent (2,3DHB-LSer)3 (lin-Ent) (Figure 3.2b), a major secreted form of Ent produced by extraintestinal
pathogenic E. coli in culture

13

and during human infections.

7

Enterobacteria carrying the

virulence-associated iroA locus encode IroE, an esterase that catalyzes monohydrolysis of the
Ent trilactone to yield lin-Ent.

7, 14, 15

ferric-Ent and ferric-lin-Ent to Scn,

Although fluorescence data support the binding of both

7, 8

researchers still have not obtained structures for these

complexes. To characterize lin-Ent interactions with Scn, we implemented an integrated MSbased platform (Figure 3.3), combing native MS, hydrogen-deuterium exchange mass
spectrometry (HDX-MS), and specific covalent footprinting MS. Native MS has few restrictions
on mass range

16, 17

and establishes ligand binding and protein complex’s stoichiometry. HDX-

MS localizes the regions of Scn that gain protection upon ligand binding (peptide-level). Specific
footprinting (Lys and Arg) adds residue specificity to the HDX data and pinpoints the binding
site (residue-level). The results show that ferric and aferric lin-Ent share a binding interface, with
ferric lin-Ent-bound Scn showing higher stability. These observations support the intriguing
possibility that Scn may capture Ent prior to iron-binding during infections.
The progressive design of our studies from “sketch” to “detail” provides holistic structural
information on solution-state Scn and Scn complexes with both ferric and aferric ligands. The
binding-site we detected for ferric and aferric lin-Ent to Scn correlates well with crystallographic
data, adding confidence to our methods. Moreover, we detected ligand induced Scn
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conformational changes that are transparent in the X-ray crystal complex structure. This
integrated platform provides structural information from stoichiometry to conformational change
and residue specific binding. The direct comparison between ferric and aferric complexes
facilitates studies of Scn in complex with both bacterial and human derived ligands as we work
toward therapeutic intervention.

Figure 3.3 Schematic representative of the MS-based platform for characterizing the interaction between Scn and
lin-Ent.

3.3 Materials and Methods
3.3.1 General
All chemicals unless otherwise stated were received from Sigma-Aldrich (St. Louis, MO)
without further purification. PBS buffer (pH 7.5), water, urea, formic acid, acetimidate
hydrochloride, methylgloxal, ammonium acetate, tetrahydrofuran (THF), iron (III) chloride,
(tris(2-carboxyethyl)phosphine) hydrochloride (TCEP), iodoacetamide (IAM), thrombin, paminobenzamidine agarose, DEAE sepharose, and C18 octadecyl-functionalized silica gel.
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Trypsin, chymotrypsin, and Glu-C were purchased from Promega (Madison, WI). ZebaTM spin
desalting column (7K MWCO) and Pierce glutathione agarose were purchased from Thermo
Scientific (Rockford, IL). SartoriusTM VivaspinTM (5K cutoff) 500 μL concentrators was from
Sartorius Corporation (Gottingen, Germany).

3.3.2 Protein and Ligand Purification
Human Scn protein was expressed and purified as previously described,

4

using the hScn-gst-

pGEX4T plasmid kindly gifted to the Henderson lab by Roland Strong. Lin-Ent was
chromatographically purified from conditioned media as follows. M63 minimal salts media
without FeSO4, supplemented with 0.2% glycerol, 10 g/mL niacin, 20 µM dipyridyl, and 200
µM 2,3-dihydroxybenzoic acid was inoculated 1:1000 with stationary phase LB culture of the
enterobactin producer UTI89 ybtS iroA, and incubated overnight at 37 oC. FeCl3 was added to
the clarified supernatant (>3 mM), until a deep purple color was obtained. Ferric catecholates
were purified on a benchtop DEAE column and eluted with 7.5 M acidified ammonium formate.
Ferric complexes were reductively dissociated with 120 mM sodium dithionite and Ent were
purified on a benchtop C18 column. Lin-Ent was purified from concentrated eluate by reversed
phase HPLC (Supelco Ascentis C18 column, cat#: 581358-U). Fractions containing pure lin-Ent
were confirmed by LC-MS, lyophilized, and stored dry at -20 oC. Lin-Ent was suspended in
ethanol + 0.1% formic acid for use, and concentration was measured via UV-vis absorbance
spectroscopy with ξ319nm = 11,200 M-1cm-1. 18, 19

3.3.3 Preparation of Protein Stock Solution
Scn (100 μM) was prepared in PBS buffer. The (2,3-DHB-LSer)3-bound Scn was prepared by
incubating the ligand (60 μM) with the Scn (40 μM) for 3 h at 25 oC. The [Fe(2,3-DHB-LSer)3]3--
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bound Scn complex was prepared by incubating FeCl3 (72 μM) and lin-Ent (60 μM) for 2 h at
room temperature, then equilibrating the mixture with Scn (40 μM) for 3 h at room temperature.

3.3.4 Native MS
A solution of 100 μM Scn was prepared in 50 mM ammonium acetate buffer. The Scn stock
solution was buffer exchanged three times in a SartoriusTM VivaspinTM concentrator (5K cutoff).
Complexes of lin-Ent and ferric lin-Ent-bound Scn were prepared by using the procedure
described above. A 5 μL sample was loaded on a nanoESI spray capillary interfaced with
Exactive Plus EMR (Thermo Scientific, Bremen, Germany) mass spectrometer operating with a
m/z range from 1000-6000. Orbitrap EMR settings were: 1500 V capillary voltage, 250 oC
capillary temperature, 200 ms injection time. Data were analyzed using Thermo Xcalibur
(Thermo Scientific, Santa Clara, CA).

3.3.5 HDX-MS
For mapping, 100 pmol of protein (in 1 μL) was diluted in PBS buffer (24 μL) at 37 oC for 5 min
and quenched by adding 25 μL quench buffer (4 M guanidine chloride, 50 mM TCEP, 25% (v/v)
trifluoroethanol with pH 2.5). After 3 min denaturation at 37 oC, the quenched sample was
diluted by 1% TFA in water (pH 2.5) to 250 μL and then injected into a custom-fabricated online pepsin column. The digested protein sample was trapped on a C8 column and separated on a
C18 analytical column.
To initiate exchange, 100 pmol of protein (1 μL) was diluted in deuterated PBS buffer (24 μL) at
37 oC. After certain times, from 10 s to 4 h, the exchange was quenched by adding 25 μL of the
quench solution mentioned above. The HD exchange data were collected on an LTQ FT mass
spectrometer (Thermo, Waltham, MA). LC elution was performed using a gradient solvent
system [solvent A: water with 0.1% formic acid, solvent B: 80% acetonitrile and 20% water with
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0.1% formic acid]. The flow rate was 100 μL/min. Gradient elution was as follows: solvent A
delivered at a linear gradient from 95% to 50% for 5.5 min, followed by a linear gradient to 0%
in 0.5 min. Solvent B was then maintained at 100% for 1.5 min before column re-equilibration.

3.3.6 Global Intact Protein Analysis
Mass spectra of intact proteins were acquired on Bruker MaXis Q-TOF (Bremen, Germany).
Protein sample (50 pmol) was injected to a custom-built platform where the protein was captured
by a C8 trap column and desalted at 200 µL/min of H2O containing 0.1% trifluoracetic acid for 3
min. After the on-line desalting, the protein was eluted with an 8 min gradient of 5% to 80%
acetonitrile in 0.1% formic acid at a flow rate of 100 µL/min.

3.3.7 Lysine and Arginine Footprinting
Experiments were performed in triplet by treating 10 μM protein with 10 mM ETAT or MG.
After 1, 3, 5, and 10 min of reaction at 37 oC, the reaction was quenched by removing the
reagents by using a Zeba spin desalting column.

3.3.8 Protein Digestion
The filtrate, after desalting, was evaporated to dryness in a vacuum centrifuge. The pellets
obtained were resuspended in 50 μL water. An aliquot of 20 μL resuspended solution was
denatured at 95 oC for 30 min, followed by adding 8 M urea, 50 mM TCEP, and 50 mM IAM.
For chymotrypsin digestion, proteins were then digested overnight with a protease:protein ratio
of 1:20 (w/w) at 37 oC. For GluC/trypsin co-digestion: proteins were digested with GluC for 8 h
at 37 oC. Trypsin was then added into the solution. The digested sample was kept at 37 oC
overnight. Pure formic acid (1 μL) was added to stop the digestion.
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3.3.9 Mass Spectrometry
The experiment was performed on a Q-Exactive Plus hybrid quadrupole orbitrap mass
spectrometer coupled with a Nanospray Flex ion source (Thermo Fisher, Santa Clara, CA). A
C18 column was custom fabricated and interfaced with an integrated emitter (75 μm × 150 mm,
1.8 μm, 100 Å). The gradient started with 98% solvent A (water with 0.1% formic acid) and
2.0% solvent B (80% acetonitrile, 0.1% formic acid), then linearly increased to 20% solvent B
over 55 min, increased to 50% solvent B over 25 min, and finally increased to 90% solvent B
over 10 min followed by a 15 min re-equilibration step. The mass range was set from m/z 3802,200 with a mass resolving power of 70 K (at m/z 200). The 15 most abundant molecular ions
were automatically chosen for fragmentation (DDA). Precursor ions were fragmented with
higher-energy collisional dissociation (HCD) with a normalized collision energy (NCE) of 32%
of maximum. The automatic gain control (AGC) targets were 5 × 105 for MS and 5 × 104 for
MS/MS acquisitions. Maximum injection times (maxIT) were 200 ms for MS and 100 ms for
MS/MS.

3.3.10 Data Analysis
For HDX data, the peptide identification was accomplished through a combination of accurate
mass analysis and LC-MS/MS using Protein Metrics (San Carlos, CA). The following
parameters were applied: nonspecific for the digestion specificity, while allowing for up to 2
missed cleavages, 60 ppm precursor mass tolerance, and 0.5 Dalton fragment mass tolerance.
Raw data were manually checked, and the list of verified peptides were submitted to HDX
Workbench (Honolulu, HI) in an automated way. Deuterium uptake was calculated as previously
described. 20 The deuterium uptake % can be calculated using the equation 3.1, where m0% is the
centroid mass of non-deuterated peptide, and m100% is the centroid mass of fully deuterated
peptide, and m is the centroid of the observed peptide.
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D=(m-m0%)/(m100%+m0%) (3.1)
For differential footprinting experiments, the LC-MS/MS data were searched for unmodified and
modified Scn digested peptides by using Byonic Software (Protein Metrics, San Carlos, CA). All
MG and ETAT modifications on Arg and Lys were added as modifications to the database. The
parameters were: 10 ppm precursor mass tolerance, 60 ppm fragment mass tolerance. The
modifications on each residue were verified by manually checking the product ion (MS/MS)
spectra.

3.4 Results and Discussion
3.4.1 Native MS
We employed nondenaturing, native MS to 1) verify the molecular weight of Scn, 2) test whether
both ferric and aferric lin-Ent bind to Scn, and 3) determine the binding stoichiometry of the
complex. Scn peaks at m/z 2068.3, 2298.0, and 2585.2 representing [Scn+10H+]10+, [Scn
+9H+]9+, and [Scn +8H+]8+, giving a MW of 20674.7 ± 3.2 Da (Figure 3.4). The peaks right next
to the main peaks indicate an impurity of Scn, likely Scn bearing a 115 Da modification.
Following equilibration with lin-Ent and Fe(III)-lin-Ent, new peaks shift by corresponding MW,
confirming that Scn binds iron-laden and iron-free state lin-Ent with 1:1 ratio (Figure 3.4).
Although the m/z shift to higher values, the charge state distribution remains the same. Given
that native protein charge states mainly depend on the folded protein’s exposed surface area, 21, 22
the unchanged charge states of the lin-Ent bound Scn complex attribute to a stable, high-order
protein structure that changes little upon binding. The surface positive charges kept same where
three protonated amino-acid side chains, shielded within the calyx, neutralize the -3 charges
carried by the ferric lin-Ent ligand.
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Binding of aferric Ent to Scn was previously reported by co-crystallization during which the Ent
was hydrolyzed.

5

Fluorescence studies of Scn ligand binding rely on tryptophan quenching,

depending on heavy-metal effect and therefore insensitive to aferric complexes. To our
knowledge, this is the first convincing solution-phase data of the aferric lin-Ent-Scn complex
with intact lin-Ent. This result further motivates us to pursue MS based studies of Scn complexes.

Figure 3.4 Native mass spectra of Scn (green square), the lin-Ent bound (yellow triangle), and the ferric lin-Entbound Scn complex (pink circle) (the concentrations of Scn, lin-Ent, and FeCl3 are 40 μM, 60 μM, and 72 μM,
respectively).
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3.4.2 Peptide-Level HDX Analysis of Scn
Because native MS provides limited structural detail on the protein-ligand interaction, we turned
to HDX to obtain site specific (peptide-level) information about potential binding sites. As a
reversible footprinting approach with minimal perturbation of the protein, HDX-MS detects
conformational changes of Scn at the peptide level. The normal quench for HDX utilizes 4 M
urea or guanidine at pH 2.5 to minimize HD back exchange. Lack of significant change in the
secondary structure of Scn from pH 7.4 to pH 2.0 indicates its high stability and forecasts
obstacles in its digestion.

1

We tried the traditional guanidine reagents, but this approach only

achieved ∼80% coverage with 37 peptides from the digest (Figure 3.5a). Traditional urea
reagent similarly gave poor coverage of the protein (data not shown). In addition, a large amount
of undigested protein peaks at 7.89 and 9.12 min as shown by the chromatogram (Figure 3.5b).
We assume that the 8-stranded antiparallel β-barrel fold makes Scn very resistant to denaturation
under normal quench buffer conditions (pH = 2.5). Therefore, we sought an alternative way to
denature Scn efficiently while minimizing HD back exchange. Using trifluoroethanol as solvent
to facilitate the denaturation of Scn, we obtained a coverage map of ∼93% of the full-length
protein sequence with 91 digested peptides (Figure 3.6a) and a negligible amount of undigested
protein (eluted at 7.78 min) (Figure 3.6b).
To obtain coarse-grained structural information, we measured the HDX for unbound Scn and
compared it with that of aferric lin-Ent-bound and ferric lin-Ent-bound Scn at 37 °C within the
same time range (10 s to 4 h) (Figure 3.7) (note that there are two additional residues at the
beginning of the expressed Scn sequence, so there is a two-residue shift of the residue numbers
compared with those described previously (e.g., R81, K125, and K127 show up as R83, K127,
and K134)).
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Figure 3.5 a) HDX mapping (showing ~80% coverage) and b) full chromatogram of Scn at 4 M guanidine
quenching condition.

Figure 3.6 a) HDX mapping (showing ~93% coverage) and b) full chromatogram of Scn at 4 M guanidine with
50% trifluoroethanol quenching condition.
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Figure 3.7 HDX kinetic plots of peptides from Scn (black) and aferric lin-Ent-bound Scn (red).
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Most of the N-terminal regions (residues 1-33) and the four-turn α-helix (residues 147-162)
exchanged over 50% with deuterium within 10 s and ended up with ∼70% deuterium uptake,
indicating these regions are flexible or solvent-exposed. Peptide 158-176 in the C-terminal
region maintained some protection, exhibiting a slow rate of HDX, which attributes to the more
ordered β-strand at the C-terminus. With these exceptions, Scn is quite rigid and structured, as
only a few peptides showed 90% exchange within 15 min at 37 °C, in agreement with the X-ray
crystal structure. 8

3.4.3 Differential HDX Analyses of the Lin-Ent-Bound Scn and Ferric LinEnt-Bound Scn Complexes.
Three positively charged residues (R81, K125, and K134) line on the highly sculpted Scn calyx
to form hybrid electrostatic/cation-π interactions with catecholate ligands.

1, 4

To probe the

siderophore-binding induced conformational changes of Scn, we performed two sets of
differential HDX experiments: 1) in the presence and absence of aferric lin-Ent (Figures 3.7 and
3.8) and 2) in the presence and absence of ferric lin-Ent (Figures 3.9 and 3.10).
The first differential HDX compared apo-Scn and aferric lin-Ent-bound Scn to locate the
siderophore binding site. To verify statistically significant differences of deuterium uptake, we
compared the sum of all the differences in the kinetic plots to the propagation error (the square
root of the sum of the squares of all standard deviations); if the accumulated differences exceed 3
times the propagation error, the probability that the region experiences statistically significant
difference reaches 99.7% (Figure 3.11a). We projected our data on the crystal structure of Scn
bound with TrenCam, an Ent analog with a nonhydrolyzable, tertiary amine backbone

5

(PDB

3HWG), and found four regions of Scn show significant deuterium uptake differences (Figure
3.8).
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Figure 3.8 Average percentage differences in deuterium uptake between apo-Scn and aferric lin-Ent-bound Scn as
per color coding on an X-ray crystal structure of TrenCam-bound Scn (PDB 3HWG). Insets: HDX kinetic data for
selected peptides in the bound and unbound state (apo-Scn (black) and aferric lin-Ent-bound Scn (red)).

Previous NMR and X-ray crystallography studies found R81, K125, and K134 (shown as R83,
K127, and K136) to be binding residues at binding pocket.

8, 10

The decreased HDX of the

peptide 124-139 (containing K127 and K136) upon lin-Ent binding coincides with the expected
cation-π interactions (Figures 3.7 and 3.8). The peptide containing R83 maintained the invariant
deuterium uptake at the bound state, possibly attribute to the 14-residue-long peptide diluted the
deuterium uptake difference (Figure 3.7). In addition, binding sites cannot always be mapped by
HDX 23 because the structural rigidity may permit the ligand to interact with the R83 side chain
without conformational affecting the adjoining peptide backbone.
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Figure 3.9 HDX kinetic plots of peptides from Scn (black) and ferric lin-Ent-bound Scn (red).
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Peptides 34-42 and 60-72 containing non-binding residues also showed protection upon lin-Ent
binding, suggesting that conformational changes happened (Figures 3.7 and 3.8). According to
the 3D structure, these two regions belong to part of the 8-stranded β-barrels. Binding to lin-Ent
may “squeeze” the core of this β barrel, inducing a tight, compact structure, thereby slowing
HDX of some β-strands of the core structure. These peptides underwent slow HDX such that the
difference in deuterium uptake became significant until 120 s. This divergence corroborates with
protection in these two regions induced by ligand binding; slow HDX and the delay before
divergence relates to the rigidity in this region of the protein.

Figure 3.10 Average percentage differences in deuterium uptake between apo-Scn and ferric lin-Ent-bound Scn as
per color coding on X-ray crystal structure of TrenCam-bound Scn (PDB 3HWG). Insets: HDX data for select
peptides in the bound and unbound state. Apo-Scn (black) and ferric lin-Ent-bound Scn (red).
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Peptide 94-109, containing part of two β-strands of the eight-stranded β barrel and a five-residue
α-helix, shows ∼50% deuterium uptake within 10 s and ∼80% in 4 h (Figures 3.7 and 3.8). The
kinetic curves diverge at the start of HDX, merge at later time points, and show high rates of
exchange throughout, suggesting that the α-helix is more solvent-exposed and likely more
flexible than the core of the protein.
We then made a second HDX differential comparison of apo-Scn and ferric lin-Ent-bound Scn to
understand the role of iron in the binding process (Figures 3.9, 3.10, and 3.11b). The same four
regions represented become protected by binding, and another region 81-94 showed noticeable
protection with ferric lin-Ent binding. Peptide 124-139 (containing the two binding residues
K127 and K136) and peptide 81-94 (containing binding residue R83) showed more significant
protection upon ferric lin-Ent binding compared to that of aferric (Figures 3.7 and 3.8). These
findings suggest that the ferric ligand induces a more compact protein structure than the aferric
ligand, potentially reflecting higher affinity binding.

3.4.4 Lys and Arg Footprinting
To pinpoint the residues that are involved in binding, we implemented specific and irreversible
covalent footprinting. This approach should give higher spatial resolution than does HDX.
Because the binding residues are likely to be Lys and Arg, we chose two water-soluble reagents,
ethyl acetimidate hydrochloride (ETAT) and methyl glyoxal (MG) (Figure 3.12), to modify Lys
and Arg, respectively. Although these types of reagents have been used for protein modifications
since the 1960s, their applications in MS-based protein footprinting were more recent. 24-28 These
labeling reactions maintain the positive charge in the protein. ETAT reacts with the amine group
of Lys by an SN2 reaction giving a unique mass shift of +41.0265 Da (Figure 3.12 a), whereas
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MG, a vicinal dicarbonyl, reacts with Arg to form a cyclic adduct that shifts the mass +72.0211
Da (Figure 3.12 b). It is common for the MG labeled product to lose one molecule of water.

Figure 3.11 The cumulative changes of lin-Ent- and ferric lin-Ent-bound Scn in HDX rates. Blue bars represent the
difference in percent deuterium uptake between the complexed and non-complexed Scn protein. a) (% deuterium
uptake of Scn - % deuterium uptake of lin-Ent bound Scn), and b) (% deuterium uptake of Scn - % deuterium uptake
of ferric lin-Ent bound Scn). The propagation error for each peptide is equal to the square root of the sum of all
squared standard deviation values for the collective measurement of (% deuterium uptake of apo - % deuterium
uptake of holo). Three times of propagation error of each peptide is depicted in grey. HDX was considered to be
significantly different between the bound and apo forms if the difference in percent deuterium uptake (blue bars)
was greater than three times the propagations error (gray).
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Figure 3.12 Labeling product of the Lys and Arg footprinting.

We evaluated the labeling performance of ETAT and MG at different time points. The ETAT
and MG labeling modification increased over the labeling time and the difference between
unbound and bound became readily apparent after 5 min (Figure 3.13), therefore we selected 5
min as the optimum labeling time to record differences among the three states.
We next asked whether ETAT and MG footprinting can identify the binding sites with good
spatial resolution. To answer this question, we digested the protein and analyzed the lysate by
LC-MS/MS. The sequence coverage of Scn achieved ∼98%, ensuring a nearly complete picture
of the protein. We integrated the extracted ion chromatogram (EIC) signal intensities for each
labeled peptide and its unlabeled counterpart to calculate the modification ratio. The labeled
peptides became more hydrophobic, eluting later than their unmodified counterparts. MS/MS
data confirm that K136 and K127 experienced ETAT modification, and R83 underwent MG
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labeling (Figures 3.14, 3.15, and 3.16). The most abundant charge states remained the same
before and after the labeling, consistent with ETAT and MG labeling maintaining a positive
charge on Lys and Arg, respectively.

Figure 3.13 ETAT and MG labeled Scn. Mass spectra of the intact, unbound Scn a) and aferric lin-Ent-bound Scn
b) as a function of ETAT footprinting time. c) Plot of the time dependent ETAT modification ratio. Mass spectra of
intact, unbound Scn d) and aferric lin-Ent-bound Scn e), as a function of MG footprinting time. f) Plot of the timedependent MG modification ratio.

We can assign with high confidence that R83, K127, and K136 interact with the ligand, causing
a decrease in their solvent accessible surface area upon binding (p value less than 0.01) (Figure
3.17). Indeed, these three positively charged residues were reported to intercalate with the
catechol rings of the ligand and form a siderophore:Scn complex. 1 The consistency between our
results and those previously published confirms our understanding of lin-Ent and Scn binding
while validating the methods presented here as useful and accurate in Scn studies.
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Figure 3.14 Chromatograms a) and product ion (MS/MS) spectra of b) unlabeled, and c) ETAT labeled
representative peptide 134-145 with +3 charge state. K136 can become ETAT modified.

Figure 3.15 Chromatograms a) and product ion (MS/MS) spectra of b) unlabeled, and c) ETAT labeled
representative peptide 125-135 with +3 charge state. K127 can become ETAT modified.
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Figure 3.16 Chromatograms a) and product ion (MS/MS) spectra of b) unlabeled, and c) MG labeled representative
peptide 82-85 with +1 charge state. R83 can become MG modified.

Figure 3.17 Labeling result of ETAT and MG on Scn, lin-Ent-bound and ferric lin-Ent-bound Scn. a) ETAT
footprinting, b) MG footprinting. (Scn light gray, lin-Ent-bound Scn dark gray, and ferric lin-Ent-bound Scn blue or
purple).
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Some residues showed more than 50% modification extent difference, but this difference did not
reach statistical significance, including R74, R132, and R142 (Figure 3.17b). To check whether
the decreased modification correlates with solvent accessible surface area (SASA), we calculated
the SASA between Scn and ferric lin-Ent bound Scn (Figure 3.18). Upon ligand binding, R74
and R142 dramatically decreased the SASA, likely causing the large MG modification difference.
Although the HDX experiment failed to provide information on peptide 73-80, the nearby
peptide 58-72 showed pronounced protection following ligand binding, which may involve R74
as part of the conformational change to reorient its position. R132 falls in the peptide 124-139
that showed a statistically significant deuterium uptake difference, suggesting this residue
associates indirectly with ligand binding. The SASA of R132 almost kept invariant in bound and
unbound states (Figure 3.17), therefore the decreased labeling ratio likely associates with the
changes in chemical reactivity, steric hindrance of nearby amino acids, and the protein
microenvironment.

Figure 3.18 Solvent accessible surface area (SASA) of Scn and ferric lin-Ent bound Scn.
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Residues K64, K100, and K126 showed no difference in ETAT footprinting, indicating that they
are not critical binding residues; however, their corresponding peptides 60-72 and 94-109,
showed significant HDX differences. This discrepancy between ETAT footprinting and HDX
results attributes to remote conformational change in this region, rather than direct ligand binding.
This may occur when stabilization of Scn upon ligand binding limits peptide backbone flexibility
and accessibility (monitored by HDX) more than the exposure of lysine residues to solvent
(monitored by ETAT footprinting). This effect was also observed in other protein systems. 29, 30

3.5 Conclusions
Native MS, HDX, and chemical footprinting support a common Scn binding interface for lin-Ent
and ferric-lin-Ent. The ferric lin-Ent interface corroborates with the model developed by the
laboratory of Roland Strong.

5

The binding pocket—Arg and Lys-rich calyx—binds both ferric

and aferric lin-Ent, though the latter molecule lacks the rigidity and anionic character compared
with ferric lin-Ent. Ent fully occupies the first coordination sphere of Fe(III) with its six
deprotonated catechol rings, making the Ent structure more rigid and sterically matched to the
Scn calyx. 2 Similar binding of ferric and aferric lin-Ent to the same Scn site suggests that Arg
and Lys form similar cation-π interaction networks with ferric and aferric catechols. Minor
differences in chemical footprinting may relate to differences in structure or stability of proteins
at different states.
These new data raise the possibility that Scn may counteract the bacterial enterobactin system
not only by sequestering Ent-bound iron but also by sequestering aferric Ent. In this model,
Fe(III) accesses to Ent, limited by sequestration of its ligands in the calyx, which is further
shielded by the outward-facing Ent serine polyester backbone. Similar interactions likely happen
for cyclic Ent, which locks in the radial symmetry of catechols. In this context, Ent linearization
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confers no clear benefit to the pathogen. It is possible that linearization facilitates pathogenesis in
other contexts 15 or that its virulence-association reflects C-glycosylation of Ent catalyzed by the
associated IroB. A better understanding of chemical microenvironments during infection may
yield more definitive answers.
The analytical platform described here will benefit studies of other ligands and mutant proteins,
particularly in conjunction with crystallographic data: it can directly compare the ligand binding
site and detect ligand-induced conformational changes of Scn for chemically labile ferric and
aferric siderophores that defy stable crystallization. Our strategy avoids the metal-dependent
fluorescence quenching and paramagnetic ferric ion interferences (e.g., as in NMR).
Finally, Lys and Arg specific footprinting, as a complement to HDX, pinpoints the residues at
the binding site, which can be expanded to detect the binding of other ligands to Scn,

13

other

proteins with stable and rigid structures, or proteins rich with Lys and Arg that are involved in
interactions via salt bridges. The intrinsic protease resistance of Scn led us to introduce
improvements in the digestion protocol for HDX by using trifluoroethanol to facilitate the
denaturation of stable and rigid Scn. We hypothesize nonaqueous solvents may have broader
advantages for other extracellular innate immune proteins and will be explored in future work.
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Chapter 4: Enhancing Proteolysis of Stable
Proteins by Organic Solvents for
Hydrogen−Deuterium Exchange Mass
Spectrometry
This chapter is based on the published paper: Chunyang Guo, Lindsey K. Steinberg, Jeffrey P.
Henderson, and Michael L. Gross “Organic solvents for enhanced proteolysis of stable proteins
for hydrogen-deuterium exchange mass spectrometry.” Anal. Chem. 2020, 92(17), 11553-11557.

4.1 Abstract
Protein digestion poses a key challenge for mass spectrometry (MS)-based structural proteomics.
Although hydrogen-deuterium exchange kinetics with MS (HDX-MS) has been routinely applied
to interrogate the high-order structure of proteins, it remains challenging for β-barrel proteins,
which are important in cellular transport. These proteins contain a continuous chain of H-bonds
that impart stability, causing difficulty in digestion for bottom-up analysis. To overcome this
impediment, we tested six different organic solvents as denaturants during on-line pepsin
digestion of three model proteins—green fluorescent protein (GFP), siderocalin (Scn), and
retinol-binding protein 4 (RBP4) to disrupt the H-bonds and hydrophobic interactions holding
together the β-sheets. Organic solvents improve digestion, generating more peptides from the
rigid β-barrel regions without compromising the ability to predict the retinol binding site on
RBP4 when adopting this proteolysis with HDX.
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4.2 Introduction
We progress the story from the previous chapter: solve the digestion problem when applying
HDX on β-barrel protein—siderocalin, comprising continuously H-bonded antiparallel β-strands.
β-barrel proteins play roles in solubilization, flux, binding, and translocation of ions and small
molecules. One of the most common alignments represented by “up-and-down” motif are formed
by antiparallel β-strands with H-bonding to the neighboring strand.

1

This feature endows β-

barrel proteins with stable and rigid structures, rendering them resistant to proteolysis. The
previous study, revealing nonaqueous solvents may have broader advantages for overcoming the
digestion problem, motivates us to systematically study the ability of organic solvents to unfold
β-barrel proteins on the HDX platform and subsequently facilitate on-line digestion.
Although MS-based structural proteomics have improved over the past decade, many challenges
remain; prominent among these is high-coverage protein digestion. We need many sets of
peptides to achieve good detection limits, accurate quantification, adequate spatial resolution,
and isoform differentiation, 2 so that we can accurately identify and quantify proteins. To ensure
high coverage in general, investigators have used several enzymes (e.g., trypsin, chymotrypsin,
LysC, LysN, AspN, GluC, ArgC, WaLP, and MaLP)

2-4

optimized activation methods (e.g., CID, ETD, and HCD)
patterns. Various surfactants, solvents, chaotropes

6

individually or in combination, or
5

to generate overlapping digestion

and pressure enhanced on-line digestion

7

also helped unfold the protein to improve the digestion efficiency.
The digestion problem becomes more serious for the HDX-MS because on-line digestion of
proteins must be fast under exchange-quenched conditions (low temperatures and a pH of 2.5).
Therefore, the experimental conditions require, of short digestion time and utilization of acidic
proteases, robust methods for digestion.

8-10

Scientists have developed many approaches to
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improve the digestion efficiency of HDX-MS including using acidic proteases with different
specificities to generate more and overlapping peptides,

11-14

utilizing tris(2-carboxyethyl)

phosphine (TCEP) or electrochemical reduction to break disulfide bonds,

15

employing

detergents 16 and incorporating high-pressure online digestion to unfold the protein. 17
When analyzing proteolytically resistant proteins, we need to primarily denature the protein to
ensure the protease can get access to the cleavage sites. Denaturation methods can be grouped
into physical treatment (e.g., heat, pressure, freezing, and irradiation) and chemical treatment
(e.g., extreme pH, organic solvents, detergents, and organic solutes like urea and guanidinium
hydrochloride).

18

Organic solvents stand out because other mentioned methods associate with

limitations to be compatible with HDX: heating the protein accelerates the HD back-exchange;
high-pressure on-line digestion system requires special equipment; and using detergents have
high risk of contaminating the mass spectrometer.
In this study, our aim was to introduce MS-friendly organic solvents to improve on-line digestion
of HDX-MS. Organic solvents, considered “turbodigestion” reagents because they efficiently
break both H-bonds and hydrophobic interactions within the polypeptide chain and between the
chain and the surrounding medium.

19, 20

Although aqueous organic solvents improved protein

digestion in tandem mass spectrometry (MS/MS)-based peptide sequencing and reduces backexchange in HDX experiments,

21

few studies were conducted, to our knowledge, in which

organic solvents were applied to improve digestion on the HDX platform.

19

This excites us to

fill this gap with a systematic study of utilizing organic solvents to improve protease-resistant
protein’s on-line digestion. Specifically, we tested six organic solvents, including polar-aprotic
and polar-protic solvents to unfold three unique water-soluble β-barrel proteins on the HDX
platform (Figure 4.1). One of the proteins is the green fluorescent protein (GFP); the other two,
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siderocalin (Scn) and retinol-binding protein 4 (RBP4), come from the lipocalin family. We also
assessed the binding site of retinol-bound RBP4 in the presence of organic solvent to ensure that
this approach does not compromise the labeling.

Figure 4.1 Six organic solvents used for unfolding β-barrel proteins.

4.3 Materials and Methods
4.3.1 General
All chemicals, solvents, pepsin, retinol, and RBP4 were purchased from Sigma-Aldrich (St.
Louis, MO). GFP was obtained from Abcam (Cambridge, MA).

4.3.2 Protein Purification
Human Scn protein was expressed and purified as described previously
pGEX4T plasmid kindly gifted to the Henderson lab by Roland Strong.
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22

using the hScn-gst-

4.3.3 Preparation of Protein Stock Solution
GFP and Scn stock solutions (100 μM) were prepared in PBS buffer. Retinol (100 μM) was
prepared in ethanol. The retinol-bound RPB4 was prepared by incubating retinol (160 μM) with
the RBP4 (80 μM) in PBS buffer for 3 h at 25 oC.

4.3.4 Quench Solution Preparation
The normal quench buffer was 4 M guanidinium hydrochloride and 50 mM TCEP in phosphate
buffered saline (PBS) buffer at pH 2.5. Quench solutions containing organic solvents were
prepared by mixing 250 μL of the buffer (8 M guanidinium hydrochloride and 100 mM TCEP in
PBS buffer) with 250 μL of the organic solvent. The pH was then adjusted to 2.5.

4.3.5 HDX Experiment
For mapping, GFP and Scn (100 pmol), and RBP4 (80 pmol) (1 μL) was diluted in PBS buffer
(24 μL) at 25 °C for 1 min (GFP) or 5 min (Scn and RBP4) and then quenched by adding 25 μL
of the quench solution. After 3 min of denaturation in the quench buffer at 37 °C (Scn and RBP4)
or 1 min of denaturation in the quench buffer at 25 °C (GFP), the sample solution was diluted to
500 μL with 1% TFA in water (pH 2.5) and then injected into a custom-fabricated, on-line
pepsin column. The peptides from digestion were trapped on a C8 column and separated with a
C18 analytical column.
To initiate exchange, protein (1 μL) was diluted with deuterated PBS buffer (24 μL) at 25 °C.
After several exchange times, from 10 s to 4 h, the exchange was stopped by adding 25 μL of the
quench solution at 37 °C for 3 min (for Scn and RBP4) or at 25 °C for 1 min (for GFP). The
quenched samples were then diluted to 500 μL by using 1% TFA in water (pH 2.5). The HDX
data were collected on a linear trap quadrupole-Fourier transform (LTQ-FT) mass spectrometer
(Thermo, Waltham, MA).
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While HDX quenching is normally conducted at low temperatures to minimize back-exchange,
highly stable proteins (like the β-barrels studied here) resist denaturation and digestion under
these conditions. We therefore used temperatures of 25 °C (GFP) and 37 °C (Scn and RBP4) to
improve the digestion at the expense of increased back exchange. Although the higher T
digestion (37 °C) will cause a ∼2.3-fold increase of back-exchange compared to room
temperature, 23 that back-exchange contributes little to the deuterium uptake differences between
the apo- and holo-protein. 21
The elution gradient for the peptic peptides started with 95% solvent A and decreased to 50%
solvent A in 5.5 min, followed by a linear gradient to 0% in 0.5 min. Solvent B was then
maintained at 100% for 1.5 min before column re-equilibration (solvent A, water with 0.1%
formic acid; solvent B, 80% acetonitrile, 20% water, 0.1% formic acid). The flow rate was 100
μL/min.

4.3.6 Data Analysis
Protein Metrics (Bync and Bynv) (San Carlos, CA) was used for the peptide identification
through a combination of accurate mass analysis and MS/MS. The parameters were: nonspecific
for the digestion specificity, while allowing up to two missed cleavages, 60 ppm precursor mass
tolerance, and 0.5 Da fragment mass tolerance. Raw data were manually checked, and the list of
verified peptides was submitted to HDX Workbench (Honolulu, HI.) Deuterium uptake was
calculated as previously described.

24

For differential HDX experiments, the LC-MS/MS data

were searched for unmodified and modified digested peptides by HDX Workbench.
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4.4 Results and Discussion
4.4.1 Green Fluorescent Protein
We started testing organic solvents on GFP (∼27 kDa), consisting of 11 β-strands with a pleatedsheet arrangement, from preparing the quench buffers to contain 4 M guanidine and 50% organic
solvent at an apparent pH 2.5. Because a pepsin column loses its enzyme activity with organic
solvents over 5%, we diluted the sample with 1% TFA (pH 2.5) to reduce organic solvent
percentage to 2.5% just before injecting the sample.

Figure 4.2 Scan statistics for GFP under quench conditions with various organic solvents. The % coverage and
number of unique peptides are annotated on the y axis.

We evaluated the digestion performance from six aspects for each solvent: sequence coverage,
number of MS/MS scans, number of unique peptides (peptide sequences unique to a protein
group), peptide length, segment length, and the effect on pepsin’s specificity.
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Adding organic solvent increased the mean GFP coverage by 5% compared with the normal
quench (i.e., 4 M guanidine) (Figure 4.2). The organic solvents did more than increasing the
sequence coverage, they also boosted the mean number of unique peptides and MS/MS scans by
∼63 and ~110%, respectively. Among the tested organic solvents, DMF showed the best
performance with twice unique peptides and nearly three times the spectral number compared
with the normal quench (Figure 4.2).

Figure 4.3 Mean length of peptic peptides found in digestion in organic solvent mixtures (GFP (red), Scn (blue),
and RBP4 (black)).

We then analyzed the peptide length and segment length. An appropriate peptide length for MS
sequencing ranges from 7 to 35 amino acids.

25

The average peptic peptide length among all

conditions is comparable (Figure 4.3). However, the average segment length decreased around
twice when adding the organic solvents. The average segment length, an approximate measure of
91

the amino acid level resolution, that can be deduced from overlapped peptides

17

(Figure 4.4a

and equation 4.1). Take the region 130-151 for example (Figure 4.4b), adding DMF generated
more overlapping peptides and decreased the average segment length from 7.3 to 4.4, which help
improve spatial resolution, sometimes even to the amino-acid level.
ASL=∑[(length of detected segments + length of undetected segments)/(number of detected segments+1)] (4.1)

We then analyzed the degree of pepsin specificity at each condition. The most frequent cleavage
events occur at the C-terminus of Phe, Leu, Tyr, and Trp, maintaining the specificity rules

7

(Figure 4.5), leading us to conclude that organic solvents keep the pepsin’s specificity.

Figure 4.4 Examples of average segment length (ASL). a) An example of segment-length determination. The
observed peptides are covered by black lines; the red dashed lines illustrate the ability to pinpoint residues or small
sequences (segments) based on peptide overlap. Six segments are present in this example; their lengths are
indicated. b) Digestion coverage of representative peptic peptide 130-151 from GFP in the presence (green lines)
and absence (black lines) of DMF.

Finally, we mapped the observed pepsin cleavage sites onto 3D structure of GFP. Many sites that
were cleaved more frequently in the presence of organic solvents locate on the rigid β-barrels
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(Figure 4.6), suggesting that organic solvents break H-bonds and disrupt hydrophobic
interactions between the β-sheets, thus increasing the exposure of these sites to pepsin and
leading to high sequence coverage.

Figure 4.5 Experimental pepsin cleavage frequency of residues in GFP under different conditions. Unique Cterminal flanking regions of the identified peptides were used for calculation of the residue frequency at the cleavage
site (blue bar), whereas green bars represent the natural occurrence of the amino acids in the GFP.
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4.4.2 Siderocalin
Given the digestion efficiency increased for GFP in organic solvents, we tested a more
challenging β-barrel protein, siderocalin (Scn, ∼ 25 kDa), from the lipocalin family. It consists of
an eight-stranded, continuously H-bonded, antiparallel β-barrel that encapsulates a ligandbinding region. The binding of siderophores or of iron and catecholate cofactors to this site is
key to the antibiotic activity of Scn. 22, 26-28

Figure 4.6 3D structure of a) GFP (PDB, 1GFL), b) Scn (PDB, 4K19), and c) RBP4 (PDB, 5NU7) (sites that are
cleaved more frequently in the presence of the organic solvent (light pink) are located on beta-barrel peptides (light
orange), sites that are cleaved only in the presence of an organic solvent are shown in light blue).

The differences in the conformation between ferric-siderophore bound- and unbound-Scn have
been revealed by HDX-MS. Previous literature reported that Scn maintains its secondary
structure at a pH range of 2-7, consistent with the high stability of β-barrel proteins. 26 Although
the coverage was an acceptable 92% under the normal quench condition (Figure 4.7), a large
amount of the Scn remained undigested (Figures 4.8a and b; the broad chromatographic peak at
5.28 min shows undigested protein, a possible source of bias in HDX 29).
Scn digestion improved dramatically (Figure 4.7) in each organic solvent tested except H2P and
i-PrOH. When Scn was quenched in 4 M guanidine in MeCN, we observed higher signal peaks
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for peptic peptides than when quenched in 4 M guanidine alone. More importantly, the
chromatogram peaks at ∼5.3 min, representing the undigested protein decreased significantly
(Figure 4.8c). Compared with the normal quench, which gave 44 unique peptides and 50 spectra,
the addition of acetonitrile gave 65 unique peptides, 104 MS/MS scans, with 98% coverage
(Figure 4.7).

Figure 4.7 Scan statistics for Scn under quench conditions with various organic solvents.

Although the average Scn peptide length, at ∼14 amino acids, kept invariant under all conditions.
The number of segments increased, leading to an ∼18% decrease of the segment length (38
segments without organic solvent vs. 45 segments with MeCN). These short and overlapped
peptides will further improve the spatial resolution.
We next analyzed the degree of specificity of pepsin on Scn under various conditions; the
digestion pattern remained almost the same (Figure 4.9). Mapping the sites that were cleaved
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more frequently in the presence of an organic solvent showed that most of them come from the
rigid β-barrels (Figure 4.6b).

a)

5.28

b)

c)

5.27

Figure 4.8 Chromatograms and mass spectra of digested Scn. a) Chromatogram of the peptides from the digestion
of Scn (and undigested protein) generated when HDX was quenched by 4 M guanidine, b) the zoom-in mass
spectrum corresponding to the peak at 5.28 min in chromatogram of Scn peptides after quenching by 4 M guanidine,
c) chromatogram of Scn quenched by buffer containing 4 M guanidine and 50% acetonitrile.
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Figure 4.9 Experimental pepsin cleavage frequency of residues in Scn under different conditions. Unique Cterminal flanking regions of the identified peptides were used for calculation of the residue frequency at the cleavage
site (blue bar), whereas green bars represent the natural occurrence of the amino acids in the Scn.

4.4.3 Retinol-Binding Protein 4
To test whether the use of organic solvents interferes with locating a ligand binding-site, we
performed HDX on bound versus unbound RBP4 (21 kDa MW) with nonaqueous solvents in the
quench buffer.
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Retinol-binding protein 1 (RBP1) (15 kDa) and RBP4 belong to a protein family that binds
hydrophobic ligands, including retinol (vitamin A alcohol). RBP1 consists of an “up- and-down”
β-strand motif giving a continuous, nearly cylindrical barrel. Several groups

30, 31

used

HDX/electrospray ionization (ESI) MS to reveal the overall deuterium incorporation of RBP1 at
the intact protein level. Careri

32

and co-workers measured HDX by matrix-assisted laser

desorption/ionization (MALDI) and ESI at the peptide-level to provide localized exchange
information, but they observed only 13 and 17 peptic peptides with ∼78% coverage for bound
and unbound cases, respectively.

Figure 4.10 Scan statistics for RBP4 under each of the quench conditions with various organic solvents.

To test the ability of organic solvents to improve the digestion and binding-site identification, we
first identified which solvent provided the best coverage of RBP4. The data show that 4 M
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guanidine with 50% methanol afforded the best result without changing pepsin’s digestion
specificity (Figures 4.10 and 4.11).

Figure 4.11 Experimental pepsin cleavage frequency of residues in RBP4 under different conditions. Unique Cterminal flanking regions of the identified peptides were used for calculation of the residue frequency at the cleavage
site (blue bar), whereas green bars represent the natural occurrence of the amino acids in the RBP4.

Consistent with the results for GFP and Scn digestion, organic solvent increased the cleavage
sites that locate on the β-barrels of RBP4. Furthermore, peptides 116-134 and 138-152, which
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were failed to be detected in the aqueous quench, were observed when adding nonaqueous
solvents (Figure 4.5). The improvement of the digestion efficiency increases the spatial
resolution, allowing for more specific identification of the protein regions whose HDX rates
change from retinol-free to retinol-bound states.

Figure 4.12 Average percentage differences in deuterium uptake with MeOH addition between retinol-free and
retinol-bound RBP4 mapped onto the X-ray crystal structure (PDB 5NU7) of retinol-bound RBP4. Insets show
retinol-free (black) and retinol-bound RBP4 (dark-green).

Next, we measured the differential HDX kinetics of retinol-free and retinol-bound RBP4 at
37 °C from 10 s to 4 h. The HDX data are consistent with earlier NMR and X-ray
crystallography results;

33

residues, of Leu35, Phe36, Ala43, Met88, Tyr90, Gln98, His104, and

Phe135 interact with the retinol. V61 was also identified as interacting with retinol but not
detected by HDX. Six regions, containing eight of the nine known binding residues, as well as an
additional region that likely underwent remote conformational changes upon binding, showed
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significant protection (Figure 4.12). To ensure that the deuterium-uptake differences between
bound and unbound cases in these regions are significant, we compared the cumulative changes
with 3 times the propagation error; if the changes exceed 3 times the error, HDX at that region is
significantly different between bound and unbound cases (Figure 4.13). Peptide 72-77 showed
distinctive HDX differences between the two states, but this region does not contain a known
binding residue. We conclude that the change in this region associates with remote
conformational change upon binding. We did not detect any measurable HDX differences for
region 47-67 that contain binding residue V61 probably because the changes at residue V61 are
small and/or diluted by the absence of changes of the 11 amino-acid long peptide. Alternatively,
it may be that the ligand binding interaction does not change the conformation of the adjoining
peptide backbone.
Compared to previous work

30

with older technology that covered 75% of the protein sequence,

we obtained nearly full coverage of RBP4 and revealed two additional regions that show
significant deuterium uptake differences (peptides 40-44 and 126-136). Furthermore, the
additional MS/MS data increased the confidence of the peptide identification, and the ∼4 times
greater number of unique overlapping peptides gave a shorter segment-length and improved the
spatial resolution (e.g., our identification of peptide 72-77 becomes more precise than the
previously reported peptide 70−84). Overall, the results show that MeOH improved mapping
without interfering with the ability of HDX to report most of the binding regions of retinolbound RBP4.

4.5 Conclusions
In conclusion, the use of organic solvents to facilitate the digestion of highly stable β-barrel
proteins provides increased protein coverage (∼95%), twice the number of unique peptides, and
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three times the number of MS/MS spectra, mostly from the rigid β-barrels. These improvements
allow a less ambiguous determination of regions where HDX differs between ligand-free and
ligand-bound states. The results coincide with the organic solvent weakening H-bonds and
disrupting hydrophobic interactions within the protein. Unfortunately, the optimum solvent is
protein-dependent, as demonstrated by DMF, acetonitrile, and methanol being the best of the
tested denaturation solvents for GFP, Scn, and RBP4, respectively. The successful footprinting

Figure 4.13 The cumulative changes of retinol-binding RBP4 in HDX rates (% dueterium uptake of holo - %
dueterium uptake of apo). The propagation error for each peptide is equal to the square root of the sum of all squared
standard deviation values for the collective measurement of (% deuterium uptake of bound) - (% deuterium uptake
of unbound). Three times the propagation errors of each peptide are depicted in gray.

of RBP4 suggests that this approach does not compromise the ability to detect conformational
changes. The next tests of the improved platform involve challenging β-barrel membrane
proteins and other proteins resistant to proteolysis on the HDX platform.
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Chapter 5: Membrane Protein Mapping in
Micelle Using Diethylpyrocarbonate
5.1 Abstract
Membrane proteins play crucial roles in cell signaling and transport and, thus, are at the heart of
the pharmacological targets. Characterizing membrane proteins’ structures at molecular level
elucidates their biological functions; however, it poses significant challenges for mass
spectrometry-based footprinting owing to the unique features of hydrophobic transmembrane
domain and the requirement of membrane to stabilize proteins. The hydrophobic reagent
diethylpyrocarbonate (DEPC), a commonly used specific covalent footprinter of water-soluble
proteins, can label up to 30% of the surface residues. The straightforward DEPC labeling
mechanism and distinctive reagent addition simplify the mass spectral analysis of the labeled
protein. Here, by utilizing vitamin K epoxide reductase (VKOR) membrane protein as protein
model, we demonstrated besides labeling the hydrophilic extramembrane domain, DEPC also
can diffuse into the hydrophobic transmembrane domain and subsequently label the region. The
labeling reaction was facilitated by tip sonication to enhance rapid reagent diffusion into
micelles. We also analyzed the correlation between residues’ modification ratio and the protein’s
high-order structure; the data strongly show nucleophilic residues match well with the % solvent
accessible surface area (% SASA); however, the weakly nucleophilic residues show poor
correlation with the % SASA. The results corroborate with footprinting outcomes of soluble
proteins. Applying relatively hydrophobic DEPC to map membrane protein indicates that the
reagent’s hydrophobicity may be a key factor for obtaining the structural information of
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membrane-spanning region. This will lead to development of more efficient footprinters for
future membrane proteins’ studies that address the relationship between reagents’ hydrophobicity
and their preferential labeling sites.

5.2 Introduction
Moving along to the membrane proteins that comprise ~30% human proteome and ~60%
therapeutic targets, we emphasize that they perform vital cellular functions, including signaling,
transport, and energy conversion.

1-8

The function-dictated-by-structure principle

9

tells us that

elucidating membrane proteins’ structures at molecular level bring understanding of their
biological functions or processes. Despite the importance of membrane proteins, the progress in
their structural characterization lags compared with the rapid advances in soluble proteins. The
difficulties originate from membrane protein’s inherent hydrophobic and dynamic properties and
the absence of polar side chains.
Current structural techniques for membrane protein study can be characterized as two major
categories: 1) rapid, low-resolution techniques (e.g., intrinsic fluorescence, CD, DLS, DSC, and
activity assay), 2) time and sample intensive, high-resolution techniques (e.g., X-ray
crystallography, NMR).

10

Methods from the first category, insensitive to protein’s local

environment change, provide an ensemble of global structures. Regularly used methods, such as
X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and cryo-EM deliver
high-resolution structural information, but they consume considerable time, require a large
amount of protein, and may miss many energetically similar conformational states. 11-15
Advanced mass spectrometry (MS)-based structural proteomics has emerged as a powerful tool
that can alleviate those limitations associated with the high-resolution techniques and offer
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moderate-resolution structural data for membrane protein studies.

11

We introduced

“footprinting” in Chapter 1 as one pivotal tool in MS-based structural proteomics, because
theoretically, it examines protein structure by determining the solvent accessibility of protein
backbone or side- chain in solution. Based on the modification sites, these techniques provide
detailed protein spatial and temporal information, including solvent accessibility, conformational
variations, dynamics, and the binding interfaces at peptide- or residue-level. In footprinting
experiments, the key to success relies on applying suitable chemical reagents that fulfill the
requirements we summarized in Chapter 1. Developing footprinters for membrane proteins—
especially for transmembrane domains—meets serious challenges: transmembrane domains
insert directly into hydrophobic lipid environment that consist predominantly of nonpolar aminoacid residues and may traverse the lipid bilayer once or several times; thus, the partition of the
footprinting reagents from aqueous solution into the hydrophobic membrane environment and
the following protein digestion for bottom-up analysis need optimization.
One of the most popular footprinters—hydroxyl radical generated by photolysis of hydrogen
peroxide,

16

radiolysis of water,

17

or other methods

proteins in a short timescale. The hydroxyl radical,

18

—modify a broad range of residues on

19-24

and other FPOP reagents

23-25

are

suitable solvent-exposure-residue probes for water-soluble proteins and for the extramembrane
domain of membrane proteins. In case of transmembrane segments, however, little modification
occurs because the hydrophobic core resists the penetration of hydrophilic hydroxyl radical. One
exception, Chance and colleagues 26, 27 utilized the radiolytic labeling methods coupled with MS
to ionize the water located in membrane-spanning region to visualize the functional water
molecules in transmembrane domain. Recently, to overcome the challenge, Manzi

28

and

colleagues developed a hydrophobic carbene footprinter with broad reactivity and achieved
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efficient labeling of the transmembrane domain of the outer membrane protein trimeric E. coli
OmpF upon irradiation at 349 nm. Our group

29

later developed a highly hydrophobic reagent

perfluoralkyl iodide to map the membrane-spanning region. However, carbene precursors require
efforts for design and synthesis, and both the above-mentioned reagents require a special laser
platform to trigger the reaction.

Figure 5.1 The chemical structure of diethylpyrocarbonate (DEPC).

Fortunately, a simple-to-use, commercially available reagent that is based on SN2 mechanism
with broad chemical specificity—diethylpyrocarbonate (DEPC)—can compensate for these
limitations, and hence enrich and diversify the choice of chemical probes for investigating
membrane proteins. DEPC, reactive with nearly 30% of the surface residues, including
nucleophilic residues His, Tyr, Thr, Ser, Cys, Lys and N terminus, with straightforward MS
analysis (distinct mass addition of +72.021 Da) can facilitate semi-quantification at the residuelevel by LC-MS/MS analysis and provide greater protein structural resolution.

30, 31

Unlike

radical reagents that need special instrumentation to activate the reaction, DEPC labeling can
readily label proteins once mix with them. This reagent has been widely applied for soluble
proteins because it is sensitive for detecting minor structural perturbations. Its solubility in
nonaqueous media also enables it to participate into the hydrophobic transmembrane domain
given its hydrophobicity (log P = 0.75) and possibly detect conformational changes of intact
membrane proteins. Hydrophobicity is often gauged using octanol-water partition coefficient or
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log P values; generally, hydrophobic reagents have positive values. Recently, DEPC along with
all other covalent probes provided restraints for integrative modeling of the membrane protein
named F-type ATP synthase from spinach chloroplasts (cATPase).

32

To our knowledge,

however, few studies have systematically addressed the DEPC labeling on integral membrane
proteins.
To address this problem, we tested whether DEPC can label the intact membrane protein by
evaluating its footprinting coverage. Our goals were to: 1) uncover the preferential labeling
region by analyzing the number of labeled residues, modification extent and locations on the 3D
structure, and 2) test whether DEPC labeling outcome correlates well with the theoretical solvent
accessible surface area (SASA). We selected vitamin K epoxide reductase (VKOR) membrane
protein model because this well-studied membrane protein has a known crystal structure 33 and is
comprised of both extramembrane and transmembrane domains (Figure 5.2). We also applied tip
sonication to partition the reagent efficiently through the membrane to the transmembrane
domain.

Figure 5.2 3D structure of vitamin K epoxide reductase (VKOR) membrane protein (PDB 3KP9).
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5.3 Materials and Methods
5.3.1 General
All reagents and solvents were commercially available and were used without further
purification. Urea, water, Tris base (>99.9% purity), acetonitrile, isopropanol, ammonium
bicarbonate, dimethyl sulfoxide (DMSO), dithiothreitol (DTT), diethylpyrocarbonate (DEPC)
and formic acid were obtained from Sigma-Aldrich (St. Louis, MO, USA). n-Dodecyl-β-Dmaltopyranoside (DDM) was obtained from Anatrace (Maumee, OH, USA). Chymotrypsin and
Tris(2-carboxyethyl)phosphine hydrochloride (TCEP-HCl) were purchased from Thermo Fisher
Scientific. (Waltham, MA, USA) A 130 Watt ultrasonic processor (Model No. VCX 1300 from
Sonics & Materials Inc., Newtown, CT) was used for tip sonication. Microcon-30 kDa
centrifugal filter unit was from Millipore Sigma (St. Louis, MO). The concentrations of all the
protein stock solutions were determined by UV absorption using Thermo Scientific™
NanoDrop™.

5.3.2 Preparation of VKOR Membrane Protein
The VKOR membrane protein was expressed with a His tag in E. coli, purified by Ni-affinity
and gel-filtration chromatography in 0.05% DDM as previously described.

33

VKOR stock

solution (1 mM) was then diluted by 0.02% DDM Tris buffer solution to 100 µM.

5.3.3 DEPC Labeling of Protein
DEPC (200 mM) was freshly prepared in acetonitrile. The final concentrations of VKOR
membrane protein for all reactions were adjusted to 10 μM. The labeling was initiated by adding
DEPC to give final concentration of 20 mM. Samples (50 µL) in 500 µL Eppendorf tubes were
sonicated in an ice bath. The probe of the ultrasonic processor was immersed into the solution,
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and the 2 cycles of sonication was at an amplitude of 20, each sonication for 2 s, followed by 10s
of rest. The reaction was quenched after 5 min at 37 oC by adding 10 mM imidazole.

5.3.4 Protein Digestion

Figure 5.3 The modified filter-aided sample preparation (FASP) workflow (adapted from reference 35).

The triplicate labeled samples were digested by using modified filter-aided sample preparation
(FASP) protocol 34-36 (Figure 5.3). Samples were transferred to ultrafiltration units, and then 200
μL of denaturing solution containing 8 M urea in 0.1 M ammonium bicarbonate (pH 8.0) was
added. The ultrafiltration units were centrifuged for 20-25 min at 10,000 g until 10 μL solution
was left in the filter. Denaturing solution (200 μL) was then added to the ultrafiltration units, and
the washing step was repeated twice. The solution in the collection tube was discarded, and 100
μL 50 mM TCEP-HCl in 0.1 M ammonium bicarbonate was added to the filter and incubated at
37 oC for 30 min. Iodoacetamide (IAA, 100 μL 100 mM) in 0.1 M ammonium bicarbonate was
added, the incubation was taken place in the dark for 30 min. The ultrafiltration units were
centrifuged at 10,000 g for ~20 min. The addition of 150 μL digestion buffer (DB, 0.1 M
ammonium bicarbonate) was followed by the centrifugation at 10,000 g for 10 min. This step
was repeated twice. Then, 60 μL DB and protease (enzyme to protein ratio 1:20) was added. The
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ultrafiltration unit was placed in the water bath at 37 °C overnight. After the incubation, new
collection tubes were replaced to collect the digested peptides. The ultrafiltration unit was
centrifuged at 10,000 g until the solution completely passed the filter membrane. The washing
step was repeated. Formic acid (1 μL) was finally added into the solution in the collection tube to
acidify the solution. The digested peptide solution was used for the LC/MS and MS/MS analysis.
The concentration of the peptides was determined by using the NanodropTM.

5.3.5 Enzyme Activity Assay
Vitamin K (1 mM) stock solution was prepared and diluted to 100 μM by isopropanol and 1 M
DTT stock solution was diluted to 12.5 mM by buffer A (0.1% DDM in 150 mM NaCl and 20
mM Tris). Buffer B was prepared as: 12.5 mM DTT (37.5 µL), 100 µM vitamin K (300 µL),
buffer A (2.66 mL). Protein samples (40 μL) were added into the CorningTM 96-well microplate
(Sigma, St Louis, MO), and 40 µL of buffer B was added to each suspension. The absorbance at
430 nm was measured every 30 s for a total of 10 min by using SpectraMax M5 multimode
microplate reader (Radnor, PA). As a control, VKOR membrane protein without either
sonication treatment or the addition of reagents was similarly monitored.

5.3.6 Circular Dichroism
Protein samples (0.25 mg/ml) were incubated in the presence or absence of DEPC in 1×PBS
buffer containing 0.02% DDM. Circular dichroism (CD) spectra were measured at room
temperature over the wavelength range of 195-340 nm at 0.5 nm intervals by using a
JASCOJ815CD spectrometer (JASCO Analytical Instruments, Tokyo, Japan).

5.3.7 Mass Spectrometry
The digested peptide solution (20 μL) was diluted by water with 0.1% FA to 50 μL. Sample (5
μL) was loaded onto a home-built silica capillary column packed with C18 reversed-phase
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material (Waters Symmetry, 5 μm, 100 Å, 75 μm×30 cm) with an integrated emitter. The HPLC
gradient was set as follows: from 2.0% solvent B (80 % acetonitrile, 0.1 % formic acid) to 65%
solvent B over 80 min, finally to 98% solvent B over 5 min at a flow rate of 0.5 μL/min,
followed by a 10 min re-equilibrated step. A Q Exactive Plus hybrid quadrupole orbitrap mass
spectrometer coupled with a Nanospray Flex ion source (Thermo Fisher, Santa Clara, CA) was
utilized for MS analysis. The spray voltage was set as 3.0 kV, and capillary temperature was set
as 250 oC. The 15 most abundant molecular ions were automatically chosen for fragmentation
(DDA) in mass spectrometer and scanned from m/z 300−2200 with a mass resolving power (RP)
of 70,000 for MS1 and 17,500 for MS2 at m/z 200 for the chromatography. Precursor ions were
produced by higher-energy collisional dissociation (HCD) with a normalized collision energy
(NCE) of 32%. The automatic gain control (AGC) targets were 5 × 105 for MS and 5 × 104 for
MS/MS acquisitions. Maximum injection times (maxIT) were 200 ms for MS and 100 ms for
MS/MS.

5.3.8 Data Analysis
The LC−MS/MS raw data were searched for unmodiﬁed and modiﬁed VKOR chymotryptic
peptides by using Byonic Software (Protein Metrics, San Carlos, CA). DEPC modiﬁcations
(+72.021 Da) on Cys, Lys, His, Ser, Thr, and Tyr were added as modiﬁcations to the database.
The parameters were: 10 ppm precursor mass tolerance, 60 ppm fragment mass tolerance, and
CID/HCD fragmentation. Modiﬁcation-sites were validated by manually checking product-ion
spectra and were double-checked with Thermo Xcalibur (a custom program from Thermo Fisher,
Santa Clara, CA).
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5.3.9 Solvent Accessible Surface Area (SASA) Calculation
PDB

file

of

VKOR

membrane

protein

(PDB

3KP9)

was

sent

to

GETAREA

(http://curie.utmb.edu/getarea.html) to calculate individual side chain SASA and %SASA by
setting the probe radius as DEPC’s radius of 4.70 Å.

5.4 Results and Discussion
5.4.1 Perturbation of the VKOR’s Structure upon the Addition of DEPC

Figure 5.4 Activity of VKOR membrane proteins before and after treatment with sonication and addition of DEPC.

Reliable structural information from covalent labeling experiment depends on whether the
protein preserves its structural integrity during the reaction. To test whether the protein maintains
its high-order structure of the protein during the footprinting, we used a bioassay where we
compared the enzyme activity in the presence and absence of DEPC. Retention of activity
provides evidence that the tertiary structure of the catalytic core that surrounded by a four
transmembrane helix bundle connected via a linker transmembrane segment with the
extracellular domain is intact,
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both for control and labeled VKOR with tip sonication
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treatment. In our case, enzyme activity remained similar in both conditions, illustrating that
under our experimental conditions, VKOR’s structure is largely maintained (if the enzyme
maintains more than two thirds of its activity, we judge that the protein maintains its high-order
structure) (Figure 5.4).

Figure 5.5 Far UV CD spectra of VKOR before and after treatment with sonication and addition of DEPC.

To reveal more detailed structural perturbation information, we characterized the structure of
control and labeled VKOR by circular dichroism (CD) spectroscopy, which monitors protein
perturbation by providing their population-weighted average structures. The overlapped CD
spectra with two distinct peaks with negative maxima at 222 and 208 nm demonstrate that the
VKOR membrane protein maintains the typical pattern of α-helix content during the reaction
(Figure 5.5).
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Taken together, the enzymology and CD experiments provide evidence that DEPC labeling
facilitated by tip sonication can maintain the VKOR membrane protein’s structural integrity.

5.4.2 DEPC Labeling of VKOR Membrane Protein

Figure 5.6 Example of LC-MS/MS analysis for VKOR labeled by DEPC. a) EIC of unmodified (black) and DEPC
modified (red) peptide 40-49 (TKLTEQPAAF). MS/MS spectra of b) unmodified and c) modified peptide 40-49.
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We met challenges of applying MS to study the membrane protein: 1) sample losses during
preparation and slow elution in chromatography because of membrane protein’s hydrophobicity
and lack of hydrophilic domains; 2) poor tryptic digestion owing to the lack of Arg and Lys
residues in transmembrane domain; 3) poor ionization efficiency associated with infrequent
occurrence of proton-accepting residues;
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4) potential contamination of mass spectrometer by

detergents or lipids. To circumvent these difficulties, we employed filter-aided sample
preparation (FASP) 34 (Figure 5.3) to reduce sample loss and thoroughly deplete detergents and
lipids and incorporated chymotrypsin digestion to perform efficient digestion and generate
peptides with better ionization efficiency for identification. The MS/MS analysis shows that
digestion gives ~100% coverage of the protein sequence. We integrated the EIC area to calculate
the modification ratio using equation 2.1 and identified the labeling site by MS/MS. For peptide
40-49 (TKLTEQPAAF), we obtained the following information: 1) The DEPC labeled peptide
eluted ~16 min later than the unmodified counterparts, demonstrating that the DEPC-modified
products became more hydrophobic (Figure 5.6a). 2) Integrating the EICs, peptide 40-49
experienced ~15% DEPC modification (Figure 5.6a). 3) The product ion spectra identify that
Lys41 underwent DEPC labeling with distinct mass shift +72.021 Da by DEPC addition on sites
2 and 6, as seen by b2 to b6 ions (Figures 5.6b and c).
DEPC labeling resulted in total 30 modified residues, including strongly nucleophilic residues
(Lys and His) and weakly nucleophilic residues (Tyr, Ser, and Thr) (Table 5.1). The strongnucleophilic residue’s modification, generally, corroborates well with %SASA, but weaknucleophilic residue’s does not.
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Table 5.1 Summary of DEPC modified residues.

Residue

Number of the modified residues

Total number of the residues

Lys

6

6

His

3

4

Ser

8

13

Thr

5

21

Tyr

8

14

5.4.3 DEPC Labeling on Strongly Nucleophilic Residues
To study systematically the DEPC labeling on VKOR, we first analyzed the reagent’s reactivity
on strongly nucleophilic residues. The labeling percentage on Lys correlates well with the
%SASA. Typically, we consider that residues with %SASA below 20% are buried and residues
with %SASA above 30% are exposed.
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The solvent-exposed residues in extramembrane

domain (K6, K8, and K216) underwent over 70% modification (Figure 5.7a). The high
modification on N-terminus reports on the dynamic and solvent-accessible character of the Nterminus, which helps explain the difficulty of crystallizing the N-terminus of the VKOR. The
location of residue Lys41 at the interface between the extramembrane and transmembrane
domain explains its relatively low modification percentage (Figure 5.7b). Although Lys97 and
Lys158, both located deep in the transmembrane segment with %SASA over 30%, should allow
both residues to undergo extensive modification (Figure 5.7b), the dramatic difference in
labeling may reflect the residue’s microenvironment. Lys97 location on an unstructured and
flexible loop permits high possibility to contact the DEPC; in contrast, Lys158 sits on a
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structured and rigid α-helix, which restricts its accessibility to DEPC. In addition, the crowded
environment between α-helix bundles also restricts access of the DEPC to Lys158 (Figure 5.7b).

Figure 5.7 DEPC labeled Lys and His. a) %SASA and modification% on Lys, b) Lys residues on VKOR 3D
structure (PDB 3KP9), c) %SASA and modification% on His, d) His residues on VKOR 3D structure (residues in
extramembrane domain are color-coded in blue, residues in transmembrane domain are color-coded in pink).

The footprinting on His residues correlates well with protein structure (Figures 5.7c and d). We
observed modification on His18 and His195 in transmembrane and H211 in extramembrane
domain, whereas we found no detectable modification on His151 with the highest %SASA
(Figure 5.7c). A better indicator of reactivity of His may be the solvent accessibility of the
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reactive Nϵ2 atom instead of the SASA of the side chain. 30 Generally, DEPC modifies His with
an Nϵ2’s SASA greater than 6 Å2; the small values of Nϵ2’s SASA of His 151 and His195 may
prevent them from footprinting.

5.4.4 DEPC Labeling on Weakly Nucleophilic Residues
Next, we investigated DEPC labeling on weakly nucleophilic residues and found that the
modification extent of these residues correlates poorly with the SASA. Ser residues underwent
less than 10% modification though some of their have %SASA above 30% (Figure 5.5a).
Projecting the labeled residues on VKOR’s 3D structure, we found that all modified Ser residues
are located at the extramembrane domain or at the interface (Figure 5.8b). Further, five out
seven labeled Ser residues (i.e., Ser56, Ser61/Ser62, S232, S267) are surrounded by charged
residues, which is consistent with the result of the previous study,
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to increase the

nucleophilicity of those sites by stabilizing the deprotonated forms and by forming hydrogen
bonding with the hydroxyl group of these residues, respectively. The relatively high modification
extent of Ser residues at the interface of the two domains suggests that the hydrophobic
environment of those residues might increase the local concentration of DEPC. We also observed
the similar trend for Tyr and Thr (Figures 5.8c, d, e, and f).
Overall, only strongly nucleophilic residues undergo modification in transmembrane domains;
their modification correlates with the side chain’s or Nϵ2 atom’s SASA. For weakly nucleophilic
residues (i.e., Ser, Thr, and Tyr), modifications occur on those sites when located at
extramembrane domain or interface. Therefore, the reactivity of DEPC in the extramembrane
domain is mainly determined by the microenvironment (e.g., existence of the charged residues,
H-bonding, and other noncovalent interactions); an observation that coincides with its
applications of soluble proteins. More importantly, in contrast to traditional water-soluble
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Figure 5.8 DEPC labeled Ser, Tyr, and Thr. a) %SASA and modification% on Ser, b) Ser residues on VKOR 3D
structure (PDB 3KP9), c) %SASA and modification% on Tyr, d) Tyr residues on VKOR 3D structure, e) %SASA
and modification% on Thr, d) Thr residues on VKOR structure. (Residues in extramembrane domain are colorcoded in blue, residues in transmembrane domain are color-coded in pink.)
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reagents, the relatively hydrophobic DEPC can label the challenging membrane-spanning
segment; the result may associate with its hydrophobicity leading to penetration into the
hydrophobic core and consequently labeling the region.

5.5 Conclusions
Using the VKOR membrane protein as a model, we demonstrated that DEPC maps the protein
structure without affecting its high-order structure. Comparing the mapping data with the
theoretical %SASA, we found that the labeling extent of strongly nucleophilic residues correlates
well with the SASA, whereas the weakly nucleophilic residues does not.

This outcome,
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shows that the

consistent with the results of a previous result on soluble protein,

microenvironment affects the reactivity of weakly nucleophilic residues. Although DEPC
predominantly footprints the extramembrane domain, an exciting result is that it can modify four
strongly nucleophilic residues that are buried deep inside the transmembrane domain.
Conventional hydrophilic reagents rarely label the hydrophobic transmembrane domain, but
DEPC can; presumably owing to its hydrophobicity. Thus, membrane-spanning regions are
likely mediated by the reagent’s hydrophobicity and its ability to diffuse through the membrane.
DEPC footprinting of the membrane protein sheds light on utilizing lipophilic reagents to
interrogate challenging transmembrane domain, and further motivates us to develop other
hydrophobic, reactive membrane protein footprinters and test the hypothesis that whether
reagent’s hydrophobicity and the accessibility to the labeling sites determine the foorprinting
efficiency of the transmembrane domain.
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Chapter 6: Evaluation of Reagent’s
Hydrophobicity on Membrane Protein
Footprinting
6.1 Abstract
Membrane proteins have important functions in biological systems. Their inherent hydrophobic
character requires detergent or lipids for solubilization and stabilization, which challenge mass
spectrometry (MS)-based structural characterization, especially for transmembrane domain. The
diethylpyrocarbonate (DEPC), described in the previous chapter, confirms the relation between
the reagent’s hydrophobicity and the extent of transmembrane domain labeling. To examine
more closely the relationship of reagent hydrophobicity and membrane protein labeling
efficiency, we chose three MS-based photochemical iodine reagents with a hydrophobicity
gradient and utilized tip sonication to enable rapid reagent diffusion into a micelle medium
occupied by the proteins. Localization and quantification of the modified residues affords
residue-level structural information as measured by proteolysis and LC-MS/MS of a model
membrane protein, vitamin K epoxide reductase (VKOR) membrane protein, and shows that the
preferential labeling sites are determined by local environment and the reagent’s hydrophobicity.
The outcome will guide for designing future customized chemical probes for membrane protein
studies. Furthermore, the novel reagents that give efficient, irreversible, and specific labeling
pattern may have wide application in interrogating membrane proteins’ structures in
biochemistry and drug discovery.
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6.2 Introduction
Membrane proteins are targets for ~60% therapeutic agents, mediating cellular processes
including signal transduction, metabolism, and transport.

1

Characterizing the structure of

membrane protein structures helps elucidate their biological functions. Although membrane
proteins are of high importance, the high-resolution structural information pertaining to them is
significantly sparse compared with soluble proteins, owing to the membrane protein’s inherent
hydrophobic and dynamic properties and to the absence of polar side chains. Often used
methods, such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and
Cryo-EM deliver high-resolution structural information, but are time-consuming, require large
amounts of proteins, and provide sparse information on conformational states. Mass
spectrometry (MS)-based methods overcome the shortcomings associated with the highresolution approaches, while providing moderate spatial resolution structural information. The
importance of membrane proteins and available biophysical tools were discussed in more detail
in Chapter 5.
Developing footprinters for extramembrane domain labeling is based on those requirements for
soluble protein labeling but must be extended owing to the additional considerations needed for
transmembrane domains. One consideration is the partition of the reagent into the hydrophobic
membrane environment. In Chapter 5, we discussed the hydroxyl radical as a commonly used
footprinter for extramembrane domain labeling and how it fails to modify the transmembrane
domain because its hydrophilicity restricts its membrane permeability. Effort to meet this
challenge include the work of utilizing specially designed carbene precursors,
iodides,

3

2

perfluoroalkyl

and DEPC to map the membrane-spanning segment, as described in the previous

chapter. The hydrophobic reagents used in the above-mentioned studies and the outcomes of
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extensive labeling of the transmembrane domains have linked the reagent’s hydrophobicity with
subsequent transmembrane labeling: point to a hydrophobic effect that may be a major driving
force for the partition of reagent into lipid environment; however, the explicit relationship
remains unclear. This question motivates us to systematically evaluate the hydrophobicity of an
appropriate reagent for transmembrane domain labeling to determine any relationship between
hydrophobicity and the extent of footprinting. We hypothesized that reagents with high
hydrophobicity would enhance the diffusion into the transmembrane domain and improve the
labeling efficiency of the region.
In this chapter, we describe the utilization of photo-activable iodine reagents to footprint VKOR
membrane protein (a description of VKOR can be found in Chapter 5). Previous studies
addressed the labeling of proteins with iodine, first applied in crystallography and
radioimmunoassay, showing it is a time-honored strategy that meets many footprinting criteria 4-8
(details in Chapter 1) because heavy iodination modification occurs within seconds to several
minutes

4, 9-13

while maintaining the quaternary structure of protein.

14

Iodination methods are

grouped in direct and indirect iodination: Direct iodination of peptides and proteins
oxidation reagent

5, 15

4, 9

by an

will cause detrimental oxidation on sensitive residues such as Met, Trp,

and Cys. Indirect iodination, such as with the Bolton-Hunter

10, 11

method and with N-

succinimidyl 3-iodobenzoate, 12, 13 can avoid the oxidation side-reaction but leads to less specific
labeling that applies to proteins that do not contain Tyr residues. Photo-activable iodine labeling
has the following features and can meet these challenges: 1) Instead of using oxidizing agents,
the labeling utilizes 248 nm wavelength laser of fast photochemical oxidation of protein (FPOP)
platform to trigger the reaction. 2) Unlike traditional iodination methods,

4, 5, 9-13, 15

the FPOP

platform readily controls the timescale of reagent that can occur in slow modifications. 16 3) The
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labeling keeps iodine footprinter’s selectivity on modification. Further, photochemical
iodination, via fast labeling by using stable organic iodine, yields stable and irreversible
iodinated derivatives, yields a straightforward readout of specific sites of modification.
contrast to hydroxyl radicals,

18-20

FPOP variants,

21, 22

carbenes,

2, 23

and DEPC,

6, 17

24, 25

4) In

photo-

activable organic iodine specifically labels His, Try, and Trp of membrane proteins,

17

simplifying the data analysis to reveal the influence of reagent’s hydrophobicity on specific
residue’s modification.
In this study, we selected three iodination reagents with similar molecular weights but widely
different hydrophobicity—4-iodobenzoic acid, 4-iodobenzyl alcohol, and iodobenzene.
Reagent’s hydrophobicity is usually defined by the partition coefficient, log P, where P
represents the equilibrium between aqueous and nonaqueous phases; generally, hydrophobic
reagents have positive log P values. Using vitamin K epoxide reductase (VKOR) membrane
protein, with both hydrophilic extramembrane and hydrophobic transmembrane domains, as
protein model, we simultaneously measured the effect of a reagent’s hydrophobicity on two
domains of the protein. We also examined whether the labeling perturbed the protein’s highorder structure by testing enzyme activity of the protein upon footprinting and comparing the
circular dichroism (CD) spectra with and without footprinting. Successful application of this
novel form of footprinting should provide a reference point for future development of chemical
probes for membrane proteins.

6.3 Materials and Methods
6.3.1 General
All reagents and solvents were commercially available and were used without further
purification. Urea, water, Tris base (>99.9% purity), acetonitrile, isopropanol, ammonium
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bicarbonate, dimethyl sulfoxide (DMSO), dithiothreitol (DTT), formic acid, 4-iodobenzoic acid,
4-iodobenzyl alcohol, and iodobenzene were obtained from Sigma-Aldrich (St. Louis, MO). nDodecyl-β-D-maltoside (DDM) was obtained from Anatrace (Maumee, OH). Chymotrypsin and
Tris(2-carboxyethyl)phosphine hydrochloride (TCEP-HCl) were purchased from Thermo Fisher
Scientific (Waltham, MA, USA). A 130 watt ultrasonic processor (Model No. VCX 1300 from
Sonics & Materials Inc., Newton, CT) was used for tip sonication. Microcon-30 kDa centrifugal
filter unit was purchased from Millipore Sigma (St. Louis, MO). The concentrations of all the
protein stock solutions were determined by UV absorption using Thermo Scientific™
NanoDrop™.

6.3.2 Preparation of Iodination Reagents
Iodobenzene and 4-iodobenzyl alcohol (1 M) were prepared in isopropanol, and 4-iodobenzoic
acid (1 M) was prepared in DMSO.

6.3.3 Preparation of VKOR Membrane Protein
The VKOR membrane protein was expressed with a His tag in E. coli, purified by Ni-affinity
and gel-filtration chromatography in 0.05% DDM as previously described.
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The VKOR stock

solution (1 mM) was then diluted by 0.02% DDM Tris buffer solution to 100 µM.

6.3.4 Tip Sonication
Samples (50 µL) in 500 µL Eppendorf tubes were sonicated in an ice bath. The probe of the
ultrasonic processor was immersed into the solution, and the 2 cycles of sonication was at an
amplitude of 20, each sonication for 2 s, followed by 10 s of rest.

6.3.5 Enzyme Activity Assay
Vitamin K (1 mM) stock solution was prepared and diluted to 100 μM by isopropanol and 1 M
DTT stock solution was diluted to 12.5 mM by buffer A (0.1% DDM in150 mM NaCl and 20
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mM Tris). Buffer B was prepared as: 12.5 mM DTT (37.5 µL), 100 µM vitamin K (300 µL),
buffer A (2.66 mL). Protein samples (40 μL) were added into the CorningTM 96-well microplate
(Sigma, MO), and 40 µL of buffer B was added to each suspension. The absorbance at 430 nm
was measured every 30 s for a total of 10 min by using SpectraMax M5 multimode microplate
reader (Radnor, PA). As a control, VKOR membrane protein without either sonication treatment
or the addition of reagents was similarly monitored.

6.3.6 Circular Dichroism
Protein samples (0.25 mg/mL) were incubated in the presence or absence of various
concentrations of iodination reagents in 1×PBS buffer containing 0.02% DDM. Circular
dichroism (CD) spectra were measured at room temperature over the wavelength range of 195340 nm at 0.5 nm intervals by using a JASCOJ815CD spectrometer (JASCO Analytical
Instruments, Tokyo, Japan).

6.3.7 Iodination of Protein on the FPOP Platform
The 50 µL sample (with various protein-to-reagent ratio) in syringe was transported through a
capillary tube with a syringe pump. A flow rate (20.6 µL/min) was calculated based on the width
of the laser spot (2.1 mm) and laser frequency (7.2 Hz) to ensure a 20% exclusion volume. The
sample solution was passed through capillary window and irradiated by a 248 nm KrF excimer
laser (15 mJ/pulse, GAM Laser Inc., Orlando, FL). All samples were collected in 500 µL
Eppendorf tubes.

6.3.8 Protein Digestion
The footprinted samples were digested by using a modified FASP protocol
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(Figure 5.3).

Samples were transferred to ultrafiltration units and followed by adding 200 μL of denaturing
solution containing 8 M urea in 0.1 M ammonium bicarbonate (pH 8.0). The ultrafiltration units
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were centrifuged for 20-25 min at 10,000 g until around 10 μL of solution was left in the filter.
Denaturing solution (200 μL) was then added to the units, followed by twice of washing steps.
The solution in the collection tube was discarded, and samples were incubated with 100 μL of 50
mM TCEP-HCl in 0.1 M ammonium bicarbonate at 37 oC for 30 min. Iodoacetamide (IAA, 100
μL 100 mM) in 0.1 M ammonium bicarbonate was then added, the alkylation was conducted in
the dark for 30 min. The ultrafiltration units were then centrifuged at 10,000 g for ~20 min.
Digestion buffer (DB, 0.1 M ammonium bicarbonate, 150 μL) was added, followed further 10
min centrifugation at 10,000 g twice. Then, 60 μL DB and protease (enzyme to protein ratio
1:20) was added. The ultrafiltration unit was placed in the water bath at 37 °C overnight. Then,
new collection tubes were replaced to collect the digested peptides. The ultrafiltration unit was
centrifuged at 10,000 g until all the solution went to the collection tube. Formic acid (1 μL) was
finally added to the solution in the collection tube to stop the digestion. The concentrations of the
peptides were determined by using the NanodropTM.

6.3.9 Mass Spectrometry
The digested peptide solution (20 μL) was diluted by water with 0.1% FA to 50 μL. An aliquot
(5 μL) was loaded onto a home-built silica capillary column packed with C18 reversed-phase
material (Waters Symmetry, 5 μm, 100 Å, 75 μm×30 cm) with an integrated emitter. The HPLC
gradient was: from 2.0% solvent B (80 % acetonitrile,0.1 % formic acid) to 65% solvent B over
80 min, finally to 98% solvent B over 5 min at a flow rate of 0.5 μL/min, followed by a 10 min
re-equilibrated step. A Q Exactive Plus hybrid quadrupole orbitrap mass spectrometer coupled
with a Nanospray Flex ion source (Thermo Fisher, Santa Clara, CA) was utilized for MS
analysis. The spray voltage was set as 3.0 kV, and capillary temperature was set as 250 oC. The
15 most abundant molecular ions were automatically chosen for fragmentation (DDA) in mass
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spectrometer and scanned from m/z 300−2200 with a resolving power (RP) of 70,000 for MS1
and 17,500 for MS2 at m/z 200 throughout the chromatography. Precursor ions were produced by
higher-energy collisional dissociation (HCD) with a normalized collision energy (NCE) of 32%.
The automatic gain control (AGC) targets were 5 × 105 for MS and 5 × 104 for MS/MS
acquisitions. Maximum injection times (maxIT) were 200 ms for MS and 100 ms for MS/MS.

6.3.10 Data Analysis
The LC−MS/MS raw data were searched for unmodiﬁed and modiﬁed VKOR membrane
chymotryptic peptides by using Byonic Software (Protein Metrics, San Carlos, CA). Iodination
modiﬁcations on Tyr, Trp, and His were added as modiﬁcations to the database. The parameters
were: 10 ppm precursor mass tolerance, 60 ppm fragment mass tolerance, and CID/HCD
fragmentation. Modiﬁcation-sites were validated by manually checking product-ion spectra and
were double-checked with Thermo Xcalibur (a custom program from Thermo Fisher, St Clara,
CA).

6.3.11 Solvent Accessible Surface Area (SASA) Calculation
PDB file of VKOR membrane protein (PDB 3KP9) was submitted to GETAREA
(http://curie.utmb.edu/getarea.html) to calculate individual side chain SASA by setting the probe
radius as that of iodide—1.98 Å.

6.4 Results and Discussion
6.4.1 Selection of New Footprinting Probes
A good membrane protein footprinter should satisfy three criteria: 1) diffuse efficiently into the
transmembrane domain; 2) achieve fast and extensive labeling; and 3) maintain membrane
protein’s native-like structure. To examine the effect of the footprinter’s hydrophobicity on
membrane protein labeling, we selected three novel photo-activatable reagents: 4-iodobenzoic
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acid, 4-iodobenzyl alcohol, and iodobenzene with a wide range of log P value (Figure 6.1). A
negative value for log P (i.e., for 4-iodobenzoic acid) means the compound distributes
preferentially in the aqueous phase, whereas a high positive log P (i.e., for 4-iodobenzyl alcohol,
iodobenzene) denotes a higher partitioning into the lipid phase. The incorporation of aromaticring is to add a lipophilic feature to facilitate reagents diffusing into the membrane-spanning
region for the same motivation as: “like dissolves like”. The ability to attach functional groups at
the para position (carboxyl group, methanol group, and hydrogen) allows a ready adjustment of
the probes’ relative hydrophobicity. We exemplify iodobenzene to show the photochemical
iodination mechanism (Figure 6.2). The laser on the FPOP platform triggers homolytic cleavage
of the C-I bond to simultaneously generate the phenyl radical (1) and the iodine radical (2). The
reactive phenyl radical then abstracts the hydrogen from the phenolic OH-group of Tyr, leading
the formation of the tyrosyl radical (3). This radical combines with the iodine radical to form (4),
which undergoes keto-enol tautomerization to form the iodinated tyrosine (5).

Figure 6.1 The chemical structures of 4-iodobenzoic acid, 4-iodobenzyl alcohol and iodobenzene.
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Photochemical iodination by 4-iodobenzoic acid was reported for soluble proteins; the rate
constant of I· is comparable to hydroxyl radical (3×1010 to 3×1011 M-1s-1), making photochemical
activation of organic iodides promising candidates for fast protein labeling. 17, 30

Figure 6.2 Mechanism of photochemical iodination.

6.4.2 Perturbation of the Proteins’ Structure Revealed by Enzyme ActivityBased Assay
One of the biggest concerns of using irreversible footprinters is their potential perturbations of
the protein’s high-order structure. In our experiments, a more serious concern is perturbation
caused by partitioning of the organic iodine by sonication. The sonication facilitates transfer of
the reagent through the membrane to the transmembrane domain, but it should do this without
changing the high-order structure of the membrane protein. Therefore, we need to test whether
tip sonication and transfer of the organic iodine affects protein structure.
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Figure 6.3 Activity of VKOR after treatment with sonication and several concentrations of iodobenzene, 4iodobenzyl alcohol, and 4-iodobenzoic acid (The (s) in the figure represents under the sonication condition).

Taking advantage of VKOR as an enzyme, we tested its enzyme activity in the presence or
absence of tip sonication and reagents, respectively. The enzyme activity of the VKOR depends
on the tertiary structure whereby a catalytic core is surrounded by a four transmembrane helix
bundle connected via a linker transmembrane segment with the extracellular domain.
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We

observed no significant structural perturbation upon tip sonication treatment because VKOR
remained more than two thirds of its activities (Figure 6.3). To screen the optimized reagent’s
concentration, we mixed VKOR membrane protein with organic iodine reagents at various
concentrations and submitted the solutions to tip sonication. All three iodination reagents at 10
mM concentration inactivated the enzyme activity dramatically. Keeping the concentration at 1
mM iodobenzene, 1 mM 4-iodobenzyl alcohol, and 100 µM 4-iodobenzoic acid, we found that
the VKOR maintained its enzyme activity (Figure 6.3).
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6.4.3 Perturbation of the Proteins’ Structure Revealed by Circular Dichroism
Spectroscopy

Figure 6.4 Far UV CD spectra of VKOR upon sonication and addition of various reagents: a) iodobenzene, 4iodobenzyl alcohol, and 4-iodobenzoic acid at a concentration of 1 mM, b) 4-iodobenzoic acid at a concentration of
10 and 100 µM.

Circular dichroism (CD) spectroscopy, an essential technique for characterizing secondary
structure of proteins in solution, can also assess a loss in protein structural integrity. The CD
signals depend on the absorption of radiation, and therefore the spectral bands associate with
distinct structural features of the protein. 31
The loss of function does not necessarily result in significant structural changes if these
disruptions do not affect substrate binding or catalytic processes.

32

To test more directly for

structural perturbation, we next characterized the structure of VKOR at different conditions by
CD spectroscopy. The spectra for VKOR exhibit the typical pattern of α-helix content with the
two negative maxima at 222 and 208 nm and membrane protein maintained its fine α-helical
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structures after the tip sonication (Figure 6.4a). Specifically, mixtures of VKOR with 4iodobenzyl alcohol and iodobenzene at 1 mM concentration after tip sonication still maintained
the α-helix content of the protein. However, for 4-iodobenzoic acid at 1 mM concentration, the
far UV CD curve was altered, illustrating disruption of the protein’s secondary structure. When
we further decreased the concentration of 4-iodobenzoic acid to 100 µM, perturbation of VKOR
was less but still on the edge of maintaining the secondary structures (Figure 6.4b).

6.4.4 Relationship between the Reagent’s Hydrophobicity and Membrane
Protein Labeling Efficiency
To generate iodine radicals, we utilized the FPOP platform with a flow system for protein
footprinting. Prior to flow and laser irradiation, we incubated the organic iodine reagents with
VKOR and submitted them to tip sonication. The solution mixture was immediately transferred
to the syringe pump and transported through the FPOP capillary. When the solution passed the
transparent window of the capillary, perpendicular to the laser beam, photolysis of organic iodide
reagents occurred to generate iodide radicals (Figure 6.5).
We first labeled the protein by photoactivation of the organic iodines at the concentration of 100
µM, under which the VKOR structure maintained a native-like structure. To locate modification
down to the residue-level, we performed LC-MS/MS analysis. Relying on the accurate masses of
chymotryptic peptides and their modified counterparts, we used extracted ion chromatograms
(EICs) to calculate the modification ratio by equation 2.1. For peptide 37-39 containing one Try,
(Figure 6.6), we found two characteristic pieces of information: 1) The mono-iodinated peptides
become more hydrophobic and elute approximately 14 min later than their unmodified
counterparts (Figure 6.6a). 2) The MS/MS spectra contain conclusive fragments that locate Y39
as the residue undergoes modification (for modified peptides’ y1 and y2 ions shift +125.90 Da,
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whereas b2 ions maintains at the same position (Figures 6.6b and c). 3) Summarizing the
bottom-up analysis, all photochemical iodination occurs on Tyr and Trp residues (Figure 6.7).
We did not observe any modification on His, which may be due to its low abundance in the
protein (VKOR only contains four His residues). 4) Despite the fact that the photolysis of
organic iodine generates two different radicals, we only observed mono-iodination without any
phenylation.

Figure 6.5 The FPOP platform used to generate iodine radical for footprinting (adapted from reference 16).

140

Figure 6.6 Example LC-MS/MS analysis for VKOR membrane protein labeled by 4-iodobenzyl alcohol (100 µM).
a) EIC for wild type (black) and mono-iodinated (red) peptide 37-39. Product-ion MS/MS spectra of b) wild type
and c) mono-iodinated peptide 37-39.

To view clearly the location of the footprinted residues, we mapped the labeling results on the
protein’s 3D structure (PDB 3KP9) (Figure 6.7). The 4-iodobenzoic acid labeled seven residues
that primarily locate at the extramembrane domain or interface, with most modification ratios
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less than 0.1%. However, we did not identify any modified residues that are located deep inside
the transmembrane domain (Figures 6.7a and b). Approximately 48% Try and Trp residues (21
Try and Trp in total) underwent 4-iodobenzyl alcohol modification, and 40% in the
transmembrane domain. On average, those in transmembrane domain underwent relatively high
average modification (1.7% for transmembrane domain vs. 1.4% modification for
extramembrane domain) (Figures 6.7c and d). The use of iodobenzene enabled labeling of 6
residues from 0.02% to 1.6%; the modifications primarily occurred in the transmembrane
domain (Y39 with 0.1% and W99 with 3% modification) (Figure 6.7e and f).

Figure 6.7 Iodination results for VKOR footprinting at reagent’s concentration of 100 µM.
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Comparing the number, the modification ratio, and the location of the labeled residue, we can see
the labeling patterns. Among the three reagents, 4-iodobenzyl alcohol modified the largest
number of residues with relatively high modification extent, which may attribute to its medium
hydrophobicity, allowing it to participate into both hydrophilic extramembrane and hydrophobic
transmembrane footprinting. More importantly, it can diffuse deep into the transmembrane
domain. The rank of modification ratio on residues in transmembrane domain (W99 > Y39 >
W64) matches well with the trend of SASA of these residues. (Table 6.1) The 4-iodobenzoic
acid mostly labeled residues in the extramembrane domain, and none in the transmembrane
domain, indicating that the monolayer lipid of micelle prevents the hydrophilic 4-iodobenzoic
acid from partitioning into the membrane and finding access to the transmembrane domain.
Iodobenzene preferred to label the membrane-spanning region with negligible modification on
the residues in extramembrane domain, but its modification in transmembrane is lower than that
of 4-iodobenzyl alcohol, which may associate with that increases diffusion efficiency of
hydrophobic reagent is offset by increases immiscibility in hydrophilic extramembrane domain.
In addition, all three reagents showed relatively high modification on N- and C-termini,
consistent with those regions as solvent-accessible or dynamic.
Analyzing the labeling results at the low reagent’s concentration, we found that the footprinting,
especially of the transmembrane domain increases, on average, with the reagent’s
hydrophobicity. Reagent’s hydrophobicity cannot predict the number of residues in
transmembrane domain that undergo modification. Rather, the high value of reagent’s
hydrophobicity is negatively correlated with the labeling performance. If the reagent becomes
too hydrophobic, its immiscibility with hydrophilic media may prevent the partitioning into the
transmembrane domain.
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Figure 6.8 Mapping iodination on VKOR at reagent’s concentration of 100 µM: a) and b) 4-iodobenzoic acid as
reagent, c) and d) 4-iodobenzyl alcohol as reagent, e) and f) iodobenzene as reagent.

6.4.5 Footprinting of VKOR Membrane Protein
Although several residues undergo modification at the reagent concentration of 100 µM, the
modification extent remains too low for footprinting purposes. Thus, we further increased the
concentration of 4-iodobenzyl alcohol and iodobenzene to 1 mM for the footprinting. The monoioidnation of Tyr and Trp dramatically increased as we increased the reagent concentration
(Figure 6.9). The di-iodination also increased, as seen by a peak shift of +251.79 Da, confirmed
by MS/MS analysis (Figure 6.10). The di-iodinated peptide became even more hydrophobic and
eluted ~7 min later than its mono-iodinated counterpart. By integrating the EIC, we calculated
that peptide 34-37 underwent 1.90% mono-iodination and 0.40% di-iodination. In the product144

ion (MS/MS) spectrum, the shift of y2 ion by +251.79 Da confirms the modification occurred on
Y36.
Table 6.1 SASA of Try and Trp residues of VKOR membrane proteins.

SASA (Å2)
95.16
156.24
14.59
184.91
19.89
118.89
55.80
52.20
0.43
15.90
68.16
39.01
0.40
21.53
52.97

Residue
Y36
Y39
W64
W99
Y117
Y120
Y132
Y163
Y178
Y204
Y207
Y228
Y252
Y262
Y277

Figure 6.9 Iodination results on VKOR at reagent concentration of 1 mM.
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We then analyzed the footprint of iodobenzene and 4-iodobenzyl alcohol when used at 1 mM
concentration. Use of iodobenzene led to labeling of 15 residues in total. The modification
mainly occurred on residues W99 and Y163 in the transmembrane domain, which have relatively
high SASA. The less than 1% modification of Y120 poorly correlates with its (high) SASA value
(193 Å2), which reflect the microenvironment surrounding the residues such as their charge,
electrostatic interactions, steric hindrance, and H-bonding. 25 In principle, using the modification
ratio as a reporter, we can deduce the solvent accessible area and locate the buried core of the
membrane proteins. Conclusions, however, based on modification ratio should be made with
caution because the intrinsic reactivity of side chains, the steric hindrance of nearby residues, and
the primary and higher order structure of protein also affect the labeling ratio. In comparison, 4iodobenzyl alcohol labeling followed the same trend, but achieved more extensive labeling.
Taken together, the data illustrate that the iodination occurred on VKOR progressively, starting
from the most accessible residues. The higher concentration labeling provides more structural
information by labeling more residues with higher labeling extent owing to more reagents
partitioning in both extramembrane and transmembrane domains. Thus, the optimized
concentration (1 mM) should work in future differential experiments to report the structural
difference between two states. Overall, 4-iodobenzyl alcohol satisfies the three criteria for being
a good membrane protein footprinter because it can: 1) efficiently diffuse into the
transmembrane segment; 2) extensively label the membrane protein’s transmembrane domain; 3)
maintain the high-order structure of VKOR membrane protein.
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Figure 6.10 Example LC-MS/MS analysis for VKOR membrane protein labeled by using 4-iodobenzyl alcohol (1
mM) as reagent. a) EIC for wild type peptide 34-37 (black), product-ion MS/MS spectra of b) wild type peptide 3437, c) mono-iodinated peptide 34-37, d) di-iodinated peptide 34-37.
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6.5 Conclusions
Methods that can characterize membrane protein, especially the hydrophobic transmembrane
domain, with improved throughput and sensitivity are highly needed. Our study showed that we
developed new membrane protein footprinters, tuned the reagent’s hydrophobicity, and
ultimately correlated the data to the protein high-order structure. We can now start to unravel
relationships between reagent’s hydrophobicity and the efficiency of footprinting a membrane
protein, especially for transmembrane domains.
To achieve the goal, we selected three photo-activable iodine reagents with differing
hydrophobicity to footprint the VKOR membrane protein and achieved fast, efficient,
irreversible, and specific labeling, facilitated by tip sonication to transfer the reagent into the
lipid media. The results show that the more hydrophobic reagent does not necessarily guarantee
higher modification in transmembrane domain. Rather, we need to tune reagent’s hydrophobicity
and concentration in the footprinting to find a “sweet spot” to yield extensive labeling of the
transmembrane domain.
This study is the first proof-of-principle effort of optimizing reagent hydrophobicity for
membrane protein’s transmembrane domain labeling. It should act as a reference to guide
choices on transporting reagents into the transmembrane domain, thus controlling the labeling of
the region. The efficient labeling of membrane protein by photo-activable organic iodine
reagents also provides insight on the potential of applying them on other membrane proteins in
vivo. Although we are still several steps away from in-cell labeling, these encouraging findings
will expand the applications of photochemical iodine reagents and open the door to investigators
to refining the relationship of reagent hydrophobicity for optimizing in vivo membrane protein
labeling.
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Chapter 7: Footprinting a Membrane Protein
in a Liposome
7.1 Abstract
Membrane proteins participate in signaling, transport, and energy conversion in cells.
Elucidating a membrane protein’s native-like structure will help define the relationship between
function and structure, but it requires studies of a protein in a membrane. To push the MS-based
footprinting boundary to interrogate the membrane protein’s structure at native condition, we
reconstituted model membrane protein vitamin K epoxide reductase (VKOR) in liposomes and
footprinted proteins with three organic iodide reagents over a range of hydrophobicity. The
labeling process was facilitated by the tip sonication to facilitate diffusion into the lipid bilayer,
thus, bringing reagents into or nearby transmembrane segment and increasing the labeling
efficiency. We evaluated each reagent’s labeling performance and examined the association of
reagent’s hydrophobicity and their preferential labeling sites in liposome system. Besides
distinguishing the VKOR’s structural difference in liposome and in micelle by comparing their
labeling pattern, we can picture the native-like VKOR membrane proteins. The results show that
photochemical iodine reagents, with fast, irreversible, and specific chemical reactivity character,
have potential to label membrane proteins at near native condition, which will lay the foundation
for future in vivo labeling. The study also provides a guidance for future development of
chemical probes for membrane protein labeling in cells.

7.2 Introduction
Membrane proteins, comprising 20-30% genes of most organisms, represents approximately
60% therapeutic targets.

1, 2

They insert into cell membranes and perform essential roles in
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signaling, transport, and metabolism.

3-5

Characterizing membrane proteins’ structures and

functions in situ not only is an alluring concept but also presents some the stumbling blocks. It
requires reconstitution of the purified membrane proteins in a membrane environment because
many membrane proteins execute their functions only when correctly oriented and inserted in the
membrane lipid bilayer.

4

Many studies, including our previous studies described in Chapter 5

and 6, stabilized membrane proteins by solubilizing them in detergent micelles, represented by
lipid monolayer with a hydrophobic core and polar surface or vice versa.

6

Micelles, however,

poorly mimic the native bilayer, may compromise protein stability and functionality, and impair
biophysical and structural analyses. 7-10 Overcoming the limitations of the micelles has motivated
our choice to evaluate liposomes as an alternative (Figure 7.1).
Liposomes, microscopic spherical-shaped phospholipid vesicles, consist of single or multiple
concentric lipid bilayers entrapping an aqueous core; they were fist investigated in 1965.

11-14

The biocompatible lipid exterior permits entrapping of membrane protein between neighboring
bilayers. The versatility confers potential to tailor the liposome structure, size, composition,
surface charge, bilayer fluidity, in various ways to provide membrane-like environment. This
control also affects biological characteristics and addresses several biological considerations.
Liposomes have many advantages, but they are less widely used than micelles in membrane
protein’s structural studies; their lower use is because lipids profoundly affect crystallization for
X-ray crystallography,

15

lipid amphiphiles complicate analysis by single particle cryo-EM,

16, 17

and lipid removal to avoid contamination in short times challenges hydrogen deuterium
exchange coupled with mass spectrometry (HDX-MS). 18, 19
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Figure 7.1 Schematic representation of micelle a) and liposome b) (adapted from reference 14).

Mass spectrometry (MS)-based irreversible footprinting can overcome the above-mentioned
challenges; it does not require the crystallization and lipids can be removed thoroughly during
overnight digestion, and it can report on protein dynamics and be used to screen binding ligands
and potential drugs.
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In our previous study in Chapter 6, we solubilized the membrane in

detergent and applied a series of photoreactive organic iodide reagents with a range of
hydrophobicity to optimize footprinting of the membrane protein, vitamin K epoxide reductase
(VKOR) (Figure 6.1). Those promising results prompts us to push the limit by applying these
reagents on membrane protein reconstituted in liposomes that more closely resemble native
conditions.
In this chapter, we evaluate the labeling performance of three photoreactive iodine reagents, 4iodobenzylic acid, 4-iodobenzyl alcohol, and iodobenzene, for VKOR reconstituted in
liposomes. We identify two questions to organize our study: 1) whether photoreactive iodine
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reagents can diffuse into the lipid bilayer and consequently label VKOR membrane protein? 2)
whether these reagents can report the structure of membrane protein under native-like
conditions? Based on the evaluation, we examined the relationship of the reagents’
hydrophobicity and the preferential labeling sites. In addition, comparing the labeling result in
liposome and in micelle helped identify the structural difference of VKOR membrane protein
under two conditions. The outcome will guide membrane-permeable probe design, enabling
future studies of in-cell labeling of membrane proteins.

7.3 Materials and Methods
7.3.1 General
All reagents and solvents were commercially available and were used without further
purification. Palmitoyloleoyl PE (POPE), palmitoyloleoyl PG (POPG), urea, water, Tris base
(>99.9% purity), isopropanol,

ammonium

bicarbonate,

dimethyl

sulfoxide (DMSO),

dithiothreitol (DTT), and formic acid were from Sigma-Aldrich (St. Louis, MO, USA). nDodecyl-β-D-maltoside (DDM) was obtained from Anatrace (Maumee, OH). Chymotrypsin and
Tris(2-carboxyethyl)phosphine hydrochloride (TCEP-HCl) were from Thermo Fisher Scientific
(Waltham, MA). A 130 watt ultrasonic processor (Model No. VCX 1300 from Sonics &
Materials Inc., Newton, CT). A microcon-30 kDa centrifugal filter unit was purchased from
Millipore Sigma (St. Louis, MO). Bio-Beads SM-2 resin was obtained from Bio-Rad (Hercules,
CA). The concentrations of all the protein stock solutions were determined by UV absorption
using Thermo Scientific™ NanoDrop™.

7.3.2 Preparation of Iodination Reagents
Stock solutions of iodobenzene and 4-iodobenzyl alcohol (1 M) were prepared in isopropanol,
and 4-iodobenzoic acid (1 M) was prepared in DMSO.
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7.3.3 Preparation of VKOR Membrane Protein
The VKOR membrane protein was expressed with a His tag in E. coli, purified by Ni-affinity
and gel-filtration chromatography in 0.05% DDM as previously described.
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The VKOR stock

solution (1 mM) was then diluted by 0.02% DDM Tris buffer solution to 100 µM.

7.3.4 Reconstitution of VKOR Membrane Protein in Liposome
Palmitoyloleoyl PE (POPE) (300 µL) and palmitoyloleoyl PG (POPG) (100 µL) were solubilized
in chloroform, and the solution was dried under an argon atmosphere for ~10 min, followed by
drying at high vacuum for at least 2 h to remove all traces of organic solvent. PBS buffer with
0.6% sodium cholate (1 mL) was added, and the resulting two-phase system was sonicated until
the solution became optically clear, leading to the formation of a stable water-in-oil emulsion.
The VKOR membrane protein (25 µL, 100 µM) was then added into the liposome suspension,
and the mixture equilibrated for 5 min. The last step was to remove the detergent by using BioBeads. Before use, Bio-Beads were washed three times by using methanol followed by five times
of washing with distilled water. Before Bio-Beads became totally dry, the suspension of the
mixture obtained was extruded through the Bio-Beads by pushing the suspension through the
filter holder. The reconstituted VKOR was stored at 4 oC overnight for further labeling
experiment.

7.3.5 Tip Sonication
Samples (50 µL) in 500 µL Eppendorf tubes were sonicated in an ice bath. The probe of the
ultrasonic processor was immersed into the solution, and the 2 cycles of sonication was at an
amplitude of 20, each sonication for 2 s, followed by 10 s of rest.

7.3.6 Iodination of Protein on the FPOP Platform
The 50 µL sample (of several protein-to-reagent concentrations) in syringe was pushed with the
syringe pump. A flow rate (20.6 µL/min) was calculated based on the width of the laser spot (2.1
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mm) and laser frequency (7.2 Hz) to ensure 20% exclusion volume. The sample solution was
passed through capillary window and irradiated by a 248 nm KrF excimer laser (15 mJ/pulse,
GAM Laser Inc., Orlando, FL). All samples were collected in 500 µL Eppendorf tubes.

7.3.7 Protein Digestion
The triplicate labeled samples were digested by using the modified FASP protocol
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(Figure

5.3). Samples were transferred to ultrafiltration units, and then 200 μL of denaturing solution
containing 8 M urea in 0.1 M ammonium bicarbonate (pH 8.0) was added. The units were
centrifuged for 20-25 min at 10,000 g until 10 μL solution was left in the filter. Denaturing
solution (200 μL) was then added to the ultrafiltration units, and the washing step was repeated
twice. The solution in the collection tube was discarded, and 100 μL 50 mM TCEP-HCl in 0.1 M
ammonium bicarbonate was added to the filter and incubated at 37 oC for 30 min. Iodoacetamide
(IAA, 100 μL 100 mM) in 0.1 M ammonium bicarbonate was added, the incubation was taken
place in the dark for 30 min. Centrifuge the ultrafiltration units at 10,000 g for ~20 min. The
addition of 150 μL digestion buffer (DB, 0.1 M ammonium bicarbonate) was followed by the
centrifugation at 10,000 g for 10 min. This step was repeated twice. Then, 60 μL DB and
protease (enzyme to protein ratio 1:20) was added. The ultrafiltration unit was placed in the
water bath at 37 °C overnight. After the overnight incubation, new collection tubes were replaced
to collect the digested peptides. The ultrafiltration unit was centrifuged at 10,000 g until the
solution completely passed the filter membrane, and the washing step was repeated. Formic acid
(1 μL) was finally added to the solution in the collection tubes for acidification. The digested
peptide solution was used for MS analysis, as described below. Concentration of the peptides
was determined by using the NanodropTM.
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7.3.8 Mass Spectrometry
The digested peptide solution (20 μL) was diluted by water with 0.1% FA to 50 μL. Samples (5
μL) was loaded onto a custom-built silica capillary column packed with C18 reversed-phase
material (Waters Symmetry, 5 μm, 100 Å, 75 μm×30 cm) with an integrated emitter. The HPLC
gradient was: from 2.0% solvent B (80 % acetonitrile, 0.1 % formic acid) to 65% solvent B over
80 min, to 98% solvent B over 5 min at a flow rate of 0.5 μL/min, followed by a 10 min
equilibration step. A Q Exactive Plus hybrid quadrupole orbitrap mass spectrometer coupled
with a Nanospray Flex ion source (Thermo Fisher, Santa Clara, CA) was utilized for LC/MS
analysis. The spray voltage was set as 3.0 kV, and capillary temperature was set at 250 oC. The
15 most abundant molecular ions were automatically chosen for fragmentation (DDA) by using a
mass spectrometer and scanned from m/z 300−2200 at a resolving power (RP) of 70,000 for MS1
and 17,500 for MS2 at m/z 200 throughout the chromatography. Precursor ions were submitted to
higher-energy collisional dissociation (HCD) with a normalized collision energy (NCE) of 32%.
The automatic gain control (AGC) targets were 5 × 105 for MS and 5 × 104 for MS/MS
acquisitions. Maximum injection times (maxIT) were 200 ms for MS and 100 ms for MS/MS.

7.3.9 Data Analysis
The LC−MS/MS raw data were searched for unmodiﬁed and modiﬁed VKOR membrane
chymotryptic peptides by using Byonic Software (Protein Metrics, San Carlos, CA). Iodination
of modiﬁcations on Tyr, Trp, and His were added to check modifications to the database. The
parameters were: 10 ppm precursor mass tolerance, 60 ppm fragment mass tolerance, and
CID/HCD fragmentation. Modiﬁcation-sites were validated by manually checking product-ion
spectra and were double-checked with Thermo Xcalibur (a custom program from Thermo Fisher,
Santa Clara, CA).
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7.3.10 Solvent Accessible Surface Area (SASA) Calculation
PDB file of VKOR membrane protein (PDB 3KP9) was submitted to GETAREA
(http://curie.utmb.edu/getarea.html) to calculate individual side chain SASA by setting probe
radius as that of iodide—1.98 Å.

7.4 Results and Discussion
We assembled the liposome to contain the VKOR membrane protein by using a widely applied
procedure,

4

involving the use of detergents. The protocol maintains the native structure of the

membrane proteins in a nondenaturing environment. To form the mixture of lipid-proteindetergent, we co-micellized the purified VKOR membrane protein with an excess of
phospholipids and detergent, followed by the removal of the detergent by Bio-Beads from the
micellar solutions, giving the progressive formation of liposomes in which the proteins were
incorporated. We then used the tip sonication to facilitate penetration of three photoactive iodine
reagents (i.e., 4-iodobenzoic acid, 4-iodobenzyl alcohol, and iodobenzene) (Figure 6.1) to allow
access to the transmembrane domain.

7.4.1 Reagent Hydrophobicity and Labeling Efficiency of VKOR in a
Liposome
In tests of the ability of the reagents to footprint the protein, we first treated VKOR with low
concentration (100 µM) and correlated the mapping results with the VKOR’s high-order
structure to reveal each reagent’s preferential labeling sites. The bottom-up analysis reveals
~100% coverage of the protein sequence. We use peptide 205-208 as an example to show our
data analysis. The mono-iodinated peptides elute ~11 min later than their unlabeled counterparts,
indicating the modified peptides are more hydrophobic. Integrating the EIC of modified and wild
type peptide 205-208, we calculated the peptide underwent 0.74% iodination (Figure 7.2a) as
seen by major peaks shifting by +125.90 Da. The product-ion (MS/MS) spectra locate the
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iodination site on Y207 from +125.90 Da shifts of the y2 and b3 ions (Figures 7.2b and c).
Summarizing the result, the modification occurred specifically on Try and Trp (Figure 7.3).

Figure 7.2 Example of LC-MS/MS analysis for VKOR reconstituted in liposome labeled by 4-iodobenzyl alcohol
(100 µM). a) EIC for wild type (gray) and mono-iodinated peptide 205-208 (red). Inset: zoom-in chromatogram of
mono-iodinated peptide 205-208. MS/MS spectra of b) wild type and c) mono-iodinated peptide 205-208.

We then mapped the photolabeling data onto the protein 3D structure (PDB 3KP9) (Figure 7.4).
The use of 4-iodobenzylic acid produced footprinting of approximately 24% Tyr and Trp
residues (21), all in the extramembrane domain with Y4 undergoing the highest modification
among the three. The use of 4-iodobenzyl alcohol labeled approximately 43% total residues, and
~33% in the extramembrane domain with a mean modification of 0.35%. On average, those in
the transmembrane segment (Y39 and W99) underwent relatively high modification over 0.76%.
The use of iodobenzene, like 4-iodobenzyl alcohol, labeled the same residues except W99, but
showed less modification extent.
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Figure 7.3 Iodination extent at several residues of VKOR membrane protein reconstituted in liposome at a reagent
concentration of 100 µM.

Evaluating each reagent’s labeling performance allowed us to establish labeling trends as a
function of reagent hydrophobicity. The 4-iodobenzylic acid only labeled residues in the
extramembrane domain (Figures 7.4a and b), consistent with the membrane’s selective
permeability that prevents hydrophilic molecules diffusing into the hydrophobic membranespanning region. The 4-iodobenzylic acid did modify Y4 with the highest modification ratio
among the three reagents, likely owing to its hydrophilic character. The 4-iodobenzyl alcohol
showed the best labeling result with the highest number of labeled residues and highest
modification ratio. It labeled Y39 and W99 in transmembrane domain more readily than residues
in the extramembrane domain, illustrating that 4-iodobenzyl alcohol can diffuse into the
161

Figure 7.4 Mapping iodination results of VKOR reconstituted in liposome with the reagent concentration of 100
µM. a) and b) 4-iodobenzylic acid as reagent, c) and d) 4-iodobenzyl alcohol as reagent, e) and f) iodobenzene as
reagent.

transmembrane domain. In addition, the outcome correlated well with the high SASA of these
residues (Table 6.1). In comparison, iodobenzene with the highest log P value can penetrate
through the lipid bilayer, but it only labeled Y39 in transmembrane domain (Figure 7.3) with
less than 0.1%. We assume that the increased hydrophobicity will increase the diffusion
efficiency, but increased immiscibility of the reagent in extramembrane domain cancel out this
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effect. All three reagents showed relatively high labeling extent on Y4, consistent with the Nterminal’s dynamic environment.
Overall, the footprinting of VKOR reconstituted in a liposome or solubilized in a micelle showed
comparable patterns: 1) The use of more hydrophilic reagent preferentially leads to preferential
labeling of the extramembrane domain. 2) Increasing the reagent’s hydrophobicity, in general,
increases the labeling efficiency of the transmembrane domain. Higher log P values of reagent,
however, do not guarantee higher modification in transmembrane region; there seems to be a
“sweet spot” where reagent’s hydrophobicity leads to optimum labeling.

7.4.2 Footprinting
Concentration

VKOR

Membrane

Protein

at

Higher

Reagent

Though several residues were modified at a reagent concentration of 100 µM, the extents were
too low for reliable footprinting. Thus, we increased the concentration of iodobenzene and 4iodobenzyl alcohol to 1 mM. Because our earlier tests that 4-iodobenzylic acid at 1 mM
concentration perturbs the VKOR structure in micelle, we excluded it from this experiment
(Figure 6.3). The modification extent increased on Tyr and Trp with the increasing reagent
concentration (Figures 7.5 and 7.6). Iodobenzene and 4-iodobenzyl alcohol labeled around 48%
and 67% Tyr and Trp residues (21), respectively. The 4-iodobenzyl alcohol still showed better
performance with twice labeled residues as did iodobenzene. The higher concentration labeling
captured more residues, including Y120, Y163, Y132, and Y178 (Figure 7.6); this result
illustrates that VKOR was progressively iodinated, starting from the most solvent accessible
residues. Because increasing the reagent’s concentration helped obtain more structural
information, thus we can use the optimized concentration (1 mM) for further differential
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experiment to report the structural difference between two states of membrane protein in
liposome.

Figure 7.5 Mapping iodination on VKOR reconstituted in a liposome by using iodobenzene and 4-iodobenzyl
alcohol at a concentration of 1mM.

7.4.3 Comparison of Labeling Pattern in Micelle and in Liposome
To address whether there are structural differences for a membrane protein in a liposome vs. a
micelle, we compared the labeling pattern at the low and high concentration of the reagents.
Generally, photochemical activation of organic iodides labeled more residues with higher
modification extent when VKOR was solubilized in a micelle compared with them a liposome.
Comparing footprinting at the lower concentration (Figures 6.6 and 7.3), we see that: although
the use of 4-iodobenzylic acid labeled two more residues (W64 and Y252) in the micelle, the
average labeling extent is comparable for two systems. Secondly, use of iodobenzene in the
liposome gave negligible labeling of Y39 and no detectable modification on W99 in
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transmembrane domain compared with labeling Y39 and W99 with an average modification
extent of ~1.7% in the micelle. However, using iodobenzene afforded almost twice the number
of residues in the extramembrane domain with higher mean modification in the liposome (0.04%
in micelle vs. 0.25% in liposome). Furthermore, use of 4-iodobenzyl alcohol showed comparable
labeling of the extramembrane domain in both media, but the modification in transmembrane
domain decreased in the liposome. The lower modifications of transmembrane domain in
liposome indicates that the less fluidic, more closely packed lipid bilayer of liposome is a better
barrier for reagents to penetrate than the monolayer of the micelle.
At higher concentration (Figure 6.8 and 7.5), the footprinting follows the same trend as that at
lower concentration. For 4-iodobenzyl alcohol, the footprinting covered two more residues in
transmembrane domain in the micelle compared with that in liposome (27% for micelle vs. 8%
for liposome). This is more evident that lipid bilayer of the liposome slows diffusion of reagents,
whereas reagents can pass more readily through the micelle monolayer. In addition, those
residues in the transmembrane domain that have high SASA can still undergo modification in
liposome (Table 6.1).
We also observed that the extramembrane domain, generally showed higher modification in
liposomes than their counterparts in micelles, suggesting that micelle better protects
extramembrane domain. The micelle forms a ring-like structure around the whole membrane
protein,

30, 31

whereas the liposome primarily traps the transmembrane segment in the lipid

bilayer while exposing the extramembrane region to solvent.
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Figure 7.6 Mapping iodination results of VKOR reconstituted in liposome with the reagent concentration of 1M. a)
and b) 4-iodobenzyl alcohol as reagent, c) and d) iodobenzene as reagent.

7.5 Conclusions
Investigators are seeking to deeply analyze membrane protein structure and function by pushing
the boundary of MS-based footprinting to characterize membrane proteins under native
condition. To resemble the native environment, in this study, we utilized the lipid bilayer of a
liposome to recruit VKOR membrane protein. In this study, we applied the organic iodine
reagents that studied in Chapter 6 on VKOR to unravel relationships between reagent’s
hydrophobicity and the efficiency of footprinting a membrane protein, especially for the
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transmembrane domain. The labeling was facilitated by tip sonication to facilitate the penetration
of reagents. The results allow us to find the relationship between the labeling reagent’s
hydrophobicity and the preferential labeling sites: the hydrophilic and hydrophobic reagents
preferentially label the extramembrane and the transmembrane domain, respectively. When
hydrophobicity enables a reagent to participate in both domains, more footprinting of the
transmembrane occurs. We also compared the footprinting patterns in liposome and in micelle
and found that the labeling in liposome decreased significantly because the lipid bilayer is a
more protective barrier than a micelle’s monolayer. The result also reveals the structural
difference between liposome and micelle that micelle protects the extramembrane domain more
significantly.
In conclusion, we extended photo-activable organic iodine reagents to modify the membrane
protein in native-like environment, revealed the relationship between the reagent and the
reagents’ hydrophobicity and the preferential labeling locations. These encouraging results
provide a guide to optimize footprinters for membrane proteins in micelle, in liposome, and even
in vivo studies.
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Chapter 8: Conclusions and Future Prospects
MS-based structural proteomics, embedded in an interdisciplinary environment that bridges
chemistry and biology, has evolved as a practical technique for studying protein and protein
complexes. Fast screening of hundreds of thousands of proteins by MS analysis of their
constituent peptides has become routine. The continued development of MS-based structural
proteomics depends on advanced instrumentation (e.g., tandem-MS, ionization methods, and
fragmentation methods), sophisticated orthogonal separation methods (e.g., reversed-phase, ionexchange, and size exclusion chromatography), mature footprinting methods (e.g., HDX,
irreversible covalent labeling, and cross-linking) and elaborate bioinformatics analysis (e.g.,
bioinformatic software, public database, and computational simulation).
Harnessing the power of MS-based structural proteomics methods, our studies described in this
thesis show that the development of new footprinters can be done and applied to MS-based
structural proteomics, solving biological problems associated with metal-binding proteins and
membrane proteins.

8.1 Conclusions
Chapter 1 introduces the fundamentals and limitations of each MS-based structural proteomics
method, addresses the biological importance of metal-binding proteins and integral membrane
proteins, and exemplifies the applications of MS-based structural proteomics.
The first part of the thesis (Chapter 2, 3, and 4) reports two metal-binding proteins-calmodulin
(CaM)and siderocalin (Scn) that regulate calcium and iron in human body. In Chapter 2, we
described the development of isotope-encoded benzhydrazide, a carboxyl group footprinter, to
interrogate the metal-binding sites of calmodulin. The outcomes show that benzhydrazide not
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only accurately locate the metal-binding sites of CaM, but also improve the MS quantification.
The small isotope effect inspires us to incorporate 15N or 13C into the footprinther in the future.
To distinguish first- and second-shell ligand binding, we need to develop a more discriminating
reagent.
In Chapter 3, we implemented an integrated MS-based platform to interrogate siderocalin (Scn),
an innate immune protein that starve pathogenic bacteria by binding to the growth-limiting
nutrients-iron ions. The progressive design of our studies from “sketch” to “detail”, starting from
native MS, over HDX-MS, to irreversible covalent labeling, provides structural information on
solution-state Scn and Scn complexes with both ferric and aferric ligands. This outcome shows
that we can integrate more MS-based structural proteomics methods into structural MS and
combine with other biophysical tools, like X-ray crystallography, NMR, and cryo-EM to
generate comprehensive pictures of protein structure.
Following upon a digestion problem of Scn when applying the HDX-MS method, we evaluated
organic solvents to facilitate the digestion of stable β-barrel proteins in Chapter 4. The
improvements allow a more complete determination of conformational change, confirming our
assumption that organic solvents weaken H-bonds and disrupt hydrophobic interactions within
the protein. We hope this method will be expanded to other stable proteins and membrane
proteins.
The second part of the thesis (Chapter 5, 6, and 7) describes development of methods for
membrane protein footprinting. In chapter 5, we systematically evaluated the DEPC’s labeling
performance on the VKOR membrane protein. The study inspired us to link the reagent’s
hydrophobicity with transmembrane domain labeling.
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To test whether the reagent’s hydrophobicity acts as the major driving force of reagent’s
diffusion into the transmembrane domain, we applied photo-activable organic iodine reagents
whose hydrophobicity can be adjusted to reveal the relationship between reagent’s
hydrophobicity and its preferential labeling sites in Chapter 6. We found that transmembrane
footprinting increases with increases in the reagent’s hydrophobicity, but too hydrophobic
reagent may have miscibility problem in hydrophilic media and lead to decreasing modification.
The study provides a guide for designing membrane protein footprinters with appropriate
hydrophobicity.
To further push the limit, in Chapter 7, we addressed footprinting of a membrane protein
reconstituted in liposome, which more resembles the native environment of a cell by using
photo-activable organic iodine reagents that we implemented in Chapter 6. These encouraging
results also provide a guide for customizing membrane protein footprinters and expand their use
for labeling membrane proteins in vivo.

8.2 Future Prospects
The continuing development of MS allows the characterization of protein structure and function
with increasing analytical depth. Mass spectrometrists are duty-bound to develop methods for a
specific protein, to assess the quality of labeling, to decide if the labeling result reveals the
protein structure, and to utilize the information-rich MS data to solve long-standing puzzles in
biology.
The next step in the development and application of MS-based structural proteomics will be
merging the unique benefits of several MS-based structural proteomics methods, as we have
exemplified with Scn study in Chapter 3. Application and refinement of these methods, including
the development of new footprinters, cross-linkers, fragmentation methods, and instruments, will
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provide a means to gain deep insights in a soluble protein’s high-order structure, dynamics, and
ligand-induced conformational change. For membrane proteins, we need to explore ways of
solubilization and to understand a footprinter’s hydrophobicity to reveal structural information of
the transmembrane domain.
Despite significant advances that have been achieved with MS-based structural proteomics, our
ultimate goal is to elucidate cellular process in vivo, MS alone, cannot solve all biological
problems. Therefore, we need to combine it with high-resolution techniques, such as cryo-EM,
X-ray crystallography, NMR, and computational modeling to obtain integrative structural
information and reveal an array of protein’s functions and interactions essential for life. We are
optimistic about the future: the constant churn of progress in MS-based structural proteomics.
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